Home Ricerca Sedi Chi siamo Organigramma Personale Contatti Didattica Login Documenti EN
Progetti in evidenza
INCIPIT
(Link esterno)

ISTAPCA
(1209 visite)

Fondo Europeo Pesca
(622 visite)

Euro-BioImaging
(Link esterno)

Fondazione Veronesi
(Link esterno)

LightDyNAmics
(1094 visite)

 INMiND
(1186 visite)

Instruct-IT
(Link esterno)

 PRIN
(1329 visite)

 eHealthNet
(1090 visite)

Ponrec
(1028 visite)

MFAG Grant
(1134 visite)

MERIT
(Link esterno)


Collegamenti

Contiene: [X]      Estesa     Autori: [X]  Tipo di lavoro: [X]
Data iniziale: Data finale: [X]      Sede: Affiliazione IBB     
    
[Pulisci modulo]


Peptide-based molecules in angiogenesis (154 visite)

D'Andrea LD, Del Gatto A, Pedone C, Benedetti E

Chem Biol Drug Des Chemical Biology And Drug Design (ISSN: 1747-0277, 1747-0285), 2006 Feb; 67(2): 115-126.



Tipo di articolo: Journal Article,

Impact factor: 2.507, Impact factor a 5 anni: 2.479

Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-33745060397&partnerID=40&md5=40af588bda1f456f7e819e3daa0b12c2

Parole chiave: Angiogenesis, Cancer, Integrins, Ischemia, Peptide, Vascular Endothelial Growth Factor, Acetyllysylleucylthreonyltryptophanylglutaminylglutamylleucyltyrosyl Glutaminylleucyllysyltyrosyllysylglycylisoleucinamide, Alanylserylserylseryltyrosylprolylleucylisoleucylhistidyltryptophanyl Arginylprolyltryptophanylalanylarginine, Alanylthreonyltryptophanylleucylprolylprolylarginine, Angiogenesis Inhibitor, Angiogenesis Modulator, Antibody, Arginylarginyllysylarginylarginylarginine, Arginylthreonylglutamylleucylasparaginylvalylglycylisoleucylaspartyl Phenylalanylasparaginyltryptophanylglutamyltyrosylproline, Asparaginylglycyltyrosylglutamylisoleucylglutamyltryptophanyltyrosylseryl Tryptophanylvalylthreonylhistidylglycylmethionyltyrosine, Becaplermin, Bevacizumab, Cysteinylthreonylthreonylhistidyltryptophanylglycylphenylalanylthreonyl Leucylcysteine, Fibroblast Growth Factor 2, Glutaminyllysylarginyllysylarginyllysyllysylserylarginyltyrosyllysylserine, Glycylaspartylglycyltyrosine, Histidylthreonylmethionyltyrosyltyrosylhistidylhistidyltyrosylglutaminyl Histidylhistidylleucine, Monoclonal Antibody Lm 609, Platelet Derived Growth Factor, Pr 39, Receptor Blocking Agent, Seryltyrosylglycylarginyllysyllysylarginylarginylglutaminylarginylarginyl Arginylprolylglutamine, Serylvalylglutaminylmethionyllysylleucine(dibenzofuran) Isoleucylisoleucylvalyllysylleucylasparaginylaspartic Acid, Tryptophanylhistidylserylaspartylmethionylglutamyltryptophanyltryptophanyl Tyrosylleucylleucylglycine, Unclassified Drug, Unindexed Drug, Valylglutamylprolylasparaginylcysteinylaspartylisoleucylhistidylvalyl Methionyltryptophanylglutamyltryptophanylglutamylcysteinylphenylalanylglutamyl Arginylleucinamide, Vasculotropin, Vasculotropin Receptor, Vitronectin Receptor, Vitronectin Receptor Antagonist, Amino Acid Sequence, Antineoplastic Activity, Cardiovascular Disease, Cell Migration, Cell Proliferation, Circulation, Clinical Trial, Complex Formation, Coronary Artery, Diabetic Foot, Drug Targeting, Electron Microscopy, Embryo Development, Endothelium Cell, Extracellular Matrix, Human, Metastasis, Molecular Biology, Molecular Dynamics, Nonhuman, Peptide Analysis, Pericyte, Priority Journal, Protein Analysis, Protein Expression, Protein Function, Protein Secretion, Protein Structure, Revascularization, Review, Smooth Muscle Fiber, Unspecified Side Effect, Vascular Tissue, Animals, Drug Design, Neovascularization, Pathologic, Structure-Activity Relationship, Serylvalylglutaminylmethionyllysylleucine (dibenzofuran) Isoleucylisoleucylvalyllysylleucylasparaginylaspartic Acid,

Affiliazioni:

*** IBB - CNR ***
Institute of Biostructure and Bioimaging, CNR and Department of Biological Sciences, University of Napoli 'Federico II', via Mezzocannone 16, 80134 Napoli, Italy



Riferimenti:

Carmeliet, P., Angiogenesis in health and disease (2003) Nat Med, 9, pp. 653-66

Hanahan, D., Folkman, J., Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis (1996) Cell, 86, pp. 353-364

Carmeliet, P., Jain, R.K., Angiogenesis in cancer and other diseases (2000) Nature, 407, pp. 249-257

Yancopoulos, G.D., Davis, S., Gale, N.W., Rudge, J.S., Wiegand, S.J., Holash, J., Vascular-specific growth factors and blood vessel formation (2000) Nature, 407, pp. 242-248

Bergers, G., Benjamin, L.E., Tumorigenesis and the angiogenic switch (2003) Nat Rev Cancer, 3, pp. 401-410

Ruoslahti, E., Specialization of tumour vasculature (2002) Nat Rev Cancer, 2, pp. 83-90

Helisch, A., Schaper, W., Angiogenesis and arteriogenesis - Not yet for prescription (2000) Z Kardiol, 89, pp. 239-244

Simons, M., Ware, J.A., Therapeutic angiogenesis in cardiovascular disease (2003) Nat Rev Drug Discov, 2, pp. 863-871

Schaper, W., Ito, W.D., Molecular mechanisms of coronary collateral vessel growth (1996) Circ Res, 79, pp. 911-919

Schultz, A., Lavie, L., Hochberg, I., Beyar, R., Stone, T., Skorecki, K., Lavie, P., Levy, A.P., Interindividual heterogeneity in the hypoxic regulation of VEGF: Significance for the development of the coronary artery collateral circulation (1999) Circulation, 100, pp. 547-552

Isner, J.M., Tissue responses to ischemia: Local and remote responses for preserving perfusion of ischemic muscle (2000) J Clin Invest, 106, pp. 615-619

Featherstone, J., Griffiths, S., From the analyst's couch. Drugs that target angiogenesis (2002) Nat Rev Drug Discov, 1, pp. 413-414

Jain, R.K., Carmeliet, P.F., Vessels of death or life (2001) Sci Am, 285, pp. 38-45

Emanueli, C., Madeddu, P., Changing the logic of therapeutic angiogenesis for ischemic disease (2005) Trends Mol Med, 11, pp. 207-216

Lee, C.G., Link, H., Baluk, P., Homer, R.J., Chapoval, S., Bhandari, V., Kang, M.J., Elias, J.A., Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung (2004) Nat Med, 10, pp. 1095-1103

Tozer, G.M., Kanthou, C., Baguley, B.C., Disrupting tumour blood vessels (2005) Nat Rev Cancer, 5, pp. 423-435

Cristofanilli, M., Charnsangavej, C., Hortobagyi, G.N., Angiogenesis modulation in cancer research: Novel clinical approaches (2002) Nat Rev Drug Discov, 1, pp. 415-426

Bouma-Ter Steege, J.C.A., Mayo, K.H., Griffioen, A.W., Angiostatic proteins and peptides (2001) Crit Rev Eukaryot Gene Expr, 11, pp. 319-334

Oku, N., Asai, T., Watanabe, K., Kuromi, K., Nagatsuka, M., Kurohane, K., Kikkawa, H., Taki, T., Anti-neovascular therapy using novel peptides homing to angiogenic vessels (2002) Oncogene, 21, pp. 2662-2669

Asai, T., Nagatsuka, M., Kuromi, K., Yamakawa, S., Kurohane, K., Ogino, K., Tanaka, M., Oku, N., Suppression of tumor growth by novel peptides homing to tumor-derived new blood vessels (2002) FEBS Lett, 510, pp. 206-210

Mayo, K.H., Dings, R.P., Flader, C., Nesmelova, I., Hargittai, B., Van Der Schaft, D.W., Van Eijk, L.I., Griffioen, A.W., Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity (2003) J Biol Chem, 278, pp. 45746-45752

Blaskovich, M.A., Lin, Q., Delarue, F.L., Sun, J., Park, H.S., Coppola, D., Hamilton, A.D., Sebti, S.M., Design of GFB-111, a platelet-derived growth factor binding molecule with antiangiogenic and anticancer activity against human tumors in mice (2000) Nat Biotechnol, 18, pp. 1065-1070

Koivunen, E., Arap, W., Valtanen, H., Rainisalo, A., Medina, O.P., Heikkila, P., Kantor, C., Pasqualini, R., Tumor targeting with a selective gelatinase inhibitor (1999) Nat Biotechnol, 17, pp. 768-774

Li, J., Post, M., Volk, R., Gao, Y., Li, M., Metais, C., Sato, K., Simons, M., PR39, a peptide regulator of angiogenesis (2000) Nat Med, 6, pp. 49-55

Hamada, Y., Nokihara, K., Okazaki, M., Fujitani, W., Matsumoto, T., Matsuo, M., Umakoshi, Y., Matsuura, N., Angiogenic activity of osteopontin-derived peptide SVVYGLR (2003) Biochem Biophys Res Commun, 310, pp. 153-157

Ferrara, N., VEGF: An update on biological and therapeutic aspects (2000) Curr Opin Biotechnol, 11, pp. 617-624

Ferrara, N., Gerber, H.P., Lecouter, J., The biology of VEGF and its receptors (2003) Nat Med, 9, pp. 669-676

Ferrara, N., Davis-Smyth, T., The biology of vascular endothelial growth factor (1997) Endocr Rev, 18, pp. 4-25

Autiero, M., Waltenberger, J., Communi, D., Kranz, A., Moons, L., Lambrechts, D., Kroll, J., Mayr-Beyrle, U., Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 (2003) Nat Med, 9, pp. 936-943

Brogi, E., Schatteman, G., Wu, T., Kim, E.A., Varticovski, L., Keyt, B., Isner, J.M., Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression (1996) J Clin Invest, 97, pp. 469-476

Abedi, H., Zachary, I., Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells (1997) J Biol Chem, 272, pp. 15442-15451

Muller, Y.A., Li, B., Christinger, H.W., Wells, J.A., Cunningham, B.C., De Vos, A.M., Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site (1997) Proc Natl Acad Sci U S a, 94, pp. 7192-7197

Muller, Y.A., Christinger, H.W., Keyt, B.A., De Vos, A.M., The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 a resolution: Multiple copy flexibility and receptor binding (1997) Structure, 5, pp. 1325-1338

Wiesmann, C., Christinger, H.W., Cochran, A.G., Cunningham, B.C., Fairbrother, W.J., Keenan, C.J., Meng, G., De Vos, A.M., Crystal structure of the complex between VEGF and a receptor-blocking peptide (1998) Biochemistry, 37, pp. 17765-17772

Pan, B., Li, B., Russell, S.J., Tom, J.Y., Cochran, A.G., Fairbrother, W.J., Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor (2002) J Mol Biol, 316, pp. 769-787

Muller, Y.A., Chen, Y., Christinger, H.W., Li, B., Cunningham, B.C., Lowman, H.B., De Vos, A.M., VEGF and the Fab fragment of a humanized neutralizing antibody: Crystal structure of the complex at 2.4 a resolution and mutational analysis of the interface (1998) Structure, 6, pp. 1153-1167

Wiesmann, C., Fuh, G., Christinger, H.W., Eigenbrot, C., Wells, J.A., De Vos, A.M., Crystal structure at 1.7 a resolution of VEGF in complex with domain 2 of the Flt-1 receptor (1997) Cell, 91, pp. 695-704

Keyt, B.A., Nguyen, H.V., Berleau, L.T., Duarte, C.M., Park, J., Chen, H., Ferrara, N., Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis (1996) J Biol Chem, 271, pp. 5638-5646

Ferrara, N., Hillan, K.J., Gerber, H.P., Novotny, W., Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer (2004) Nat Rev Drug Discov, 3, pp. 391-400

Cooke, S.P., Boxer, G.M., Lawrence, L., Pedley, R.B., Spencer, D.I., Begent, R.H., Chester, K.A., A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: Receptor complex (2001) Cancer Res, 61, pp. 3653-3659

Lu, D., Shen, J., Vil, M.D., Zhang, H., Jimenez, X., Bohlen, P., Witte, L., Zhu, Z., Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity (2003) J Biol Chem, 278, pp. 43496-43507

Prewett, M., Huber, J., Li, Y., Santiago, A., O'Connor, W., King, K., Overholser, J., Hicklin, D.J., Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors (1999) Cancer Res, 59, pp. 5209-5218

Willett, C.G., Boucher, Y., Di Tomaso, E., Duda, D.G., Munn, L.L., Tong, R.T., Chung, D.C., Fischman, A.J., Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (2004) Nat Med, 10, pp. 145-147

Underiner, T.L., Ruggeri, B., Gingrich, D.E., Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy (2004) Curr Med Chem, 11, pp. 731-745

Sun, J., Wang, D.A., Jain, R.K., Carie, A., Paquette, S., Ennis, E., Blaskovich, M.A., Sebti, S.M., Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors (2005) Oncogene, 24, pp. 4701-4709

Sun, J., Blaskovich, M.A., Jain, R.K., Delarue, F., Paris, D., Brem, S., Wotoczek-Obadia, M., Sebti, S.M., Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor (2004) Cancer Res, 64, pp. 3586-3592

Holash, J., Davis, S., Papadopoulos, N., Croll, S.D., Ho, L., Russell, M., Boland, P., Fandl, J.P., VEGF-Trap: A VEGF blocker with potent antitumor effects (2002) Proc Natl Acad Sci U S a, 99, pp. 11393-11398

Kim, E.S., Serur, A., Huang, J., Manley, C.A., McCrudden, K.W., Frischer, J.S., Soffer, S.Z., Yamashiro, D.J., Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma (2002) Proc Natl Acad Sci U S a, 99, pp. 11399-11404

Takei, Y., Kadomatsu, K., Yuzawa, Y., Matsuo, S., Muramatsu, T., A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics (2004) Cancer Res, 64, pp. 3365-3370

Niethammer, A.G., Xiang, R., Becker, J.C., Wodrich, H., Pertl, U., Karsten, G., Eliceiri, B.P., Reisfeld, R.A., A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth (2002) Nat Med, 8, pp. 1369-1375

Fairbrother, W.J., Christinger, H.W., Cochran, A.G., Fuh, G., Keenan, C.J., Quan, C., Shriver, S.K., Cunningham, B.C., Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site (1998) Biochemistry, 37, pp. 17754-17764

Binetruy-Tournaire, R., Demangel, C., Malavaud, B., Vassy, R., Rouyre, S., Kraemer, M., Plouet, J., Mazie, J.C., Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis (2000) EMBO J, 19, pp. 1525-1533

El-Mousawi, M., Tchistiakova, L., Yurchenko, L., Pietrzynski, G., Moreno, M., Stanimirovic, D., Ahmad, D., Alakhov, V., A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library (2003) J Biol Chem, 278, pp. 46681-46691

Hetian, L., Ping, A., Shumei, S., Xiaoying, L., Luowen, H., Jian, W., Lin, M., Chengchao, S., A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor (2002) J Biol Chem, 277, pp. 43137-43142

An, P., Lei, H., Zhang, J., Song, S., He, L., Jin, G., Liu, X., Shou, C., Suppression of tumor growth and metastasis by a VEGFR-1 antagonizing peptide identified from a phage display library (2004) Int J Cancer, 111, pp. 165-173

Zilberberg, L., Shinkaruk, S., Lequin, O., Rousseau, B., Hagedorn, M., Costa, F., Caronzolo, D., Bello, L., Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor (2003) J Biol Chem, 278, pp. 35564-35573

Bae, D.G., Gho, Y.S., Yoon, W.H., Chae, C.B., Arginine-rich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis (2000) J Biol Chem, 275, pp. 13588-13596

Jia, H., Jezequel, S., Lohr, M., Shaikh, S., Davis, D., Soker, S., Selwood, D., Zachary, I., Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF (2001) Biochem Biophys Res Commun, 283, pp. 164-173

Piossek, C., Schneider-Mergener, J., Schirner, M., Vakalopoulou, E., Germeroth, L., Thierauch, K.H., Vascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF (1999) J Biol Chem, 274, pp. 5612-5619

Albini, A., Soldi, R., Giunciuglio, D., Giraudo, E., Benelli, R., Primo, L., Noonan, D., Bussolino, F., The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells (1996) Nat Med, 2, pp. 1371-1375

D'Andrea, L.D., Iaccarino, G., Fattorusso, R., Sorriento, D., Carannante, C., Capasso, D., Trimarco, B., Pedone, C., Targeting angiogenesis: Structural characterization and biological properties of a de novo engineered VEGF mimicking peptide (2005) Proc Natl Acad Sci U S a, 102, pp. 14215-14220

Giancotti, F.G., Ruoslahti, E., Integrin signaling (1999) Science, 285, pp. 1028-1032

Van Der Flier, A., Sonnenberg, A., Function and interactions of integrins (2001) Cell Tissue Res, 305, pp. 285-298

Brooks, P.C., Clark, R.A., Cheresh, D.A., Requirement of vascular integrin alpha v beta 3 for angiogenesis (1994) Science, 264, pp. 569-571

Schlaepfer, D.D., Hauck, C.R., Sieg, D.J., Signaling through focal adhesion kinase (1999) Prog Biophys Mol Biol, 71, pp. 435-478

Longhurst, C.M., Jennings, L.K., Integrin-mediated signal transduction (1998) Cell Mol Life Sci, 54, pp. 514-526

Stupack, D.G., Puente, X.S., Boutsaboualoy, S., Storgard, C.M., Cheresh, D.A., Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins (2001) J Cell Biol, 155, pp. 459-470

Xiong, J.P., Stehle, T., Diefenbach, B., Zhang, R., Dunker, R., Scott, D.L., Joachimiak, A., Arnaout, M.A., Crystal structure of the extracellular segment of integrin alpha Vbeta3 (2001) Science, 294, pp. 339-345

Gottschalk, K.E., Gunther, R., Kessler, H., A three-state mechanism of integrin activation and signal transduction for integrin alpha(v)beta(3) (2002) Chembiochem, 3, pp. 470-473

Pierschbacher, M.D., Ruoslahti, E., Variants of the cell recognition site of fibronectin that retain attachment-promoting activity (1984) Proc Natl Acad Sci U S a, 81, pp. 5985-5988

Ruoslahti, E., Pierschbacher, M.D., New perspectives in cell adhesion: RGD and integrins (1987) Science, 238, pp. 491-497

Albelda, S.M., Buck, C.A., Integrins and other cell adhesion molecules (1990) FASEB J, 4, pp. 2868-2880

Humphries, M.J., The molecular basis and specificity of integrin-ligand interactions (1990) J Cell Sci, 97 (4), pp. 585-592

Hautanen, A., Gailit, J., Mann, D.M., Ruoslahti, E., Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor (1989) J Biol Chem, 264, pp. 1437-1442

Miller, W.H., Keenan, R.M., Willette, R.N., Lark, M.W., Identification and in vivo efficacy of small-molecule antagonists of integrin alphavbeta3 (the vitronectin receptor) (2000) Drug Discov Today, 5, pp. 397-408

Marugan, J.J., Manthey, C., Anaclerio, B., Lafrance, L., Lu, T., Markotan, T., Leonard, K.A., Tomczuk, B., Design, synthesis, and biological evaluation of novel potent and selective alphavbeta3/alphavbeta5 integrin dual inhibitors with improved bioavailability. Selection of the molecular core (2005) J Med Chem, 48, pp. 926-934

Goodman, S.L., Holzemann, G., Sulyok, G.A., Kessler, H., Nanomolar small molecule inhibitors for alphav(beta)6, alphav(beta)5, and alphav(beta)3 integrins (2002) J Med Chem, 45, pp. 1045-1051

Haubner, R., Gratias, R., Diefenbach, B., Goodman, S., Joachimiak, A., Kessler, H., Structural and functional aspects of RGD-containing cyclic pentapeptides as highly potent and selective integrin alphaVbeta3 antagonists (1996) J Am Chem Soc, 118, pp. 7461-7472

Mitjans, F., Meyer, T., Fittschen, C., Goodman, S., Jonczyk, A., Marshall, J.F., Reyes, G., Piulats, J., In vivo therapy of malignant melanoma by means of antagonists of alphav integrins (2000) Int J Cancer, 87, pp. 716-723

Dechantsreiter, M.A., Planker, E., Matha, B., Lohof, E., Holzemann, G., Jonczyk, A., Goodman, S.L., Kessler, H., N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists (1999) J Med Chem, 42, pp. 3033-3040

Sulyok, G.A., Gibson, C., Goodman, S.L., Holzemann, G., Wiesner, M., Kessler, H., Solid-phase synthesis of a nonpeptide RGD mimetic library: New selective alphavbeta3 integrin antagonists (2001) J Med Chem, 44, pp. 1938-1950

Belvisi, L., Bernardi, A., Checchia, A., Manzoni, L., Potenza, D., Scolastico, C., Castorina, M., Pisano, C., Potent integrin antagonists from a small library of RGD-including cyclic pseudopeptides (2001) Org Lett, 3, pp. 1001-1004

Posey, J.A., Khazaeli, M.B., Delgrosso, A., Saleh, M.N., Lin, C.Y., Huse, W., Lobuglio, A.F., A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer (2001) Cancer Biother Radiopharm, 16, pp. 125-132

Kessler, H., Peptide conformations: Part 16. Solid-state carbon-13 NMR spectra of cyclotriprolines (1982) Angew Chem Int Ed Engl, 94, pp. 509-520

Aumailley, M., Gurrath, M., Muller, G., Calvete, J., Timpl, R., Kessler, H., Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1 (1991) FEBS Lett, 291, pp. 50-54

Pfaff, M., Tangemann, K., Muller, B., Gurrath, M., Muller, G., Kessler, H., Timpl, R., Engel, J., Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins (1994) J Biol Chem, 269, pp. 20233-20238

Haubner, R., Schmitt, W., Holzemann, G., Goodman, S., Jonczyk, A., Kessler, H., Cyclic RGD peptides containing beta-turn mimetics (1996) J Am Chem Soc, 118, pp. 7881-7891

Haubner, R., Finsinger, D., Kessler, H., Stereoisomeric peptide libraries and peptidomimetics for designing selective inhibitors of the avb3 integrin for a new cancer therapy (1997) Angew Chem Int Ed Engl, 36, pp. 1374-1389

Kawaguchi, M., Hosotani, R., Ohishi, S., Fujii, N., Tulachan, S.S., Koizumi, M., Toyoda, E., Imamura, M., A novel synthetic Arg-Gly-Asp-containing peptide cyclo(-RGDf = V-) is the potent inhibitor of angiogenesis (2001) Biochem Biophys Res Commun, 288, pp. 711-717

Coleman, P.J., Brashear, K.M., Hunt, C.A., Hoffman, W.F., Hutchinson, J.H., Breslin, M.J., McVean, C.A., Ma, B., Non-peptide alpha(v)beta(3) antagonists. identification of potent RGD mimetics incorporating novel beta-amino acids as aspartic acid replacements (2002) Bioorg Med Chem Lett, 3, pp. 31-34

Kumar, C.C., Malkowski, M., Yin, Z., Tanghetti, E., Yaremko, B., Nechuta, T., Varner, J., Armstrong, L., Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist (2001) Cancer Res, 61, pp. 2232-2238

Urbahns, K., Harter, M., Albers, M., Schmidt, D., Stelte-Ludwig, B., Bruggemeier, U., Vaupel, A., Gerdes, C., Biphenyls as potent vitronectin receptor antagonists (2002) Bioorg Med Chem Lett, 12, pp. 205-208

Van Well, R.M., Overkleeft, H.S., Van Der Marel, G.A., Bruss, D., Thibault, G., De Groot, P.G., Van Boom, J.H., Overhand, M., Solid-phase synthesis of cyclic RGD-furanoid sugar amino acid peptides as integrin inhibitors (2003) Bioorg Med Chem Lett, 13, pp. 331-334

Manthey, C., Lee, Y., Wang, A., Crysler, C., Zhao, S., Bone, R.F., Tomczuk, B.E., Characterization of O-guanidines as novel alphaVbeta3 inhibitors (2001) Proc Am Assoc Cancer Res, 42, p. 368

Marugan, J.J., Haslow, K.D., Crysler, C., Design, synthesis, and biochemical evaluation of novel alpha V beta 3 integrin ligands (2004) Bioorg Med Chem Lett, 14, pp. 4553-4555

Eskens, F.A., Dumez, H., Hoekstra, R., Perschl, A., Brindley, C., Bottcher, S., Wynendaele, W., Van Oosterom, A.T., Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumours (2003) Eur J Cancer, 39, pp. 917-926

Pasqualini, R., Koivunen, E., Ruoslahti, E., Alpha v integrins as receptors for tumor targeting by circulating ligands (1997) Nat Biotechnol, 15, pp. 542-546

Gante, J., Peptidomimetics - Tailored enzyme inhibitors (1994) Angew Chem Int Ed Engl, 33, pp. 1699-1720

Gante, J., Azapeptides (1989) Synthesis, pp. 405-413

Gould, R.J., Polokoff, M.A., Friedman, P.A., Huang, T.F., Holt, J.C., Cook, J.J., Niewiarowski, S., Disintegrins: A family of integrin inhibitory proteins from viper venoms (1990) Proc Soc Exp Biol Med, 195, pp. 168-171

Niewiarowski, S., McLane, M.A., Kloczewiak, M., Stewart, G.J., Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors (1994) Semin Hematol, 31, pp. 289-300

Gan, Z.R., Gould, R.J., Jacobs, J.W., Friedman, P.A., Polokoff, M.A., Echistatin. a potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus (1988) J Biol Chem, 263, pp. 19827-19832

Marcinkiewicz, C., Rosenthal, L.A., Mosser, D.M., Kunicki, T.J., Niewiarowski, S., Immunological characterization of eristostatin and echistatin binding sites on alpha IIb beta 3 and alpha V beta 3 integrins (1996) Biochem J, 317 (3), pp. 817-825

Zartler, E.R., Shapiro, M.J., Fragonomics: Fragment-based drug discovery (2005) Curr Opin Chem Biol, 9, pp. 366-370

Yamada, K.M., Even-Ram, S., Integrin regulation of growth factor receptors (2002) Nat Cell Biol, 4, pp. E75-E76

Brooks, P.C., Stromblad, S., Sanders, L.C., Von Schalscha, T.L., Aimes, R.T., Stetler-Stevenson, W.G., Quigley, J.P., Cheresh, D.A., Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 (1996) Cell, 85, pp. 683-693

De, S., Razorenova, O., McCabe, N.P., O'Toole, T., Qin, J., Byzova, T.V., VEGF-integrin interplay controls tumor growth and vascularization (2005) Proc Natl Acad Sci U S a, 102, pp. 7589-7594

Mizukami, Y., Jo, W.S., Duerr, E.M., Gala, M., Li, J., Zhang, X., Zimmer, M.A., Chung, D.C., Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells (2005) Nat Med, 11, pp. 992-997

Carmeliet, P., VEGF gene therapy: Stimulating angiogenesis or angiomagenesis (2000) Nat Med, 6, pp. 1102-1103

Weis, S.M., Cheresh, D.A., Pathophysiological consequences of VEGF-induced vascular permeability (2005) Nature, 437, pp. 497-504

Liu, S., Edwards, D.S., 99mTc-labeled small peptides as diagnostic radiopharmaceuticals (1999) Chem Rev, 99, pp. 2235-2268

Li, S., Peck-Radosavljevic, M., Kienast, O., Preitfellner, J., Hamilton, G., Kurtaran, A., Pirich, C., Dudczak, R., Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphy (2003) Ann Oncol, 14, pp. 1274-1277

Haubner, R., Wester, H.J., Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies (2004) Curr Pharm des, 10, pp. 1439-1455

Miller, J.C., Pien, H.H., Sahani, D., Sorensen, A.G., Thrall, J.H., Imaging angiogenesis: Applications and potential for drug development (2005) J Natl Cancer Inst, 97, pp. 172-187

Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., Holash, J., Vascular-specific growth factors and blood vessel formation (2000) Nature, 407, pp. 242-248

Isner, J. M., Tissue responses to ischemia: Local and remote responses for preserving perfusion of ischemic muscle (2000) J Clin Invest, 106, pp. 615-619

Jain, R. K., Carmeliet, P. F., Vessels of death or life (2001) Sci Am, 285, pp. 38-45

Lee, C. G., Link, H., Baluk, P., Homer, R. J., Chapoval, S., Bhandari, V., Kang, M. J., Elias, J. A., Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung (2004) Nat Med, 10, pp. 1095-1103

Tozer, G. M., Kanthou, C., Baguley, B. C., Disrupting tumour blood vessels (2005) Nat Rev Cancer, 5, pp. 423-435

Mayo, K. H., Dings, R. P., Flader, C., Nesmelova, I., Hargittai, B., Van Der Schaft, D. W., Van Eijk, L. I., Griffioen, A. W., Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity (2003) J Biol Chem, 278, pp. 45746-45752

Blaskovich, M. A., Lin, Q., Delarue, F. L., Sun, J., Park, H. S., Coppola, D., Hamilton, A. D., Sebti, S. M., Design of GFB-111, a platelet-derived growth factor binding molecule with antiangiogenic and anticancer activity against human tumors in mice (2000) Nat Biotechnol, 18, pp. 1065-1070

Muller, Y. A., Li, B., Christinger, H. W., Wells, J. A., Cunningham, B. C., De Vos, A. M., Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site (1997) Proc Natl Acad Sci U S a, 94, pp. 7192-7197

Muller, Y. A., Christinger, H. W., Keyt, B. A., De Vos, A. M., The crystal structure of vascular endothelial growth factor (VEGF) refined to 1. 93 a resolution: Multiple copy flexibility and receptor binding (1997) Structure, 5, pp. 1325-1338

Muller, Y. A., Chen, Y., Christinger, H. W., Li, B., Cunningham, B. C., Lowman, H. B., De Vos, A. M., VEGF and the Fab fragment of a humanized neutralizing antibody: Crystal structure of the complex at 2. 4 a resolution and mutational analysis of the interface (1998) Structure, 6, pp. 1153-1167

Keyt, B. A., Nguyen, H. V., Berleau, L. T., Duarte, C. M., Park, J., Chen, H., Ferrara, N., Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis (1996) J Biol Chem, 271, pp. 5638-5646

Cooke, S. P., Boxer, G. M., Lawrence, L., Pedley, R. B., Spencer, D. I., Begent, R. H., Chester, K. A., A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: Receptor complex (2001) Cancer Res, 61, pp. 3653-3659

Willett, C. G., Boucher, Y., Di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Fischman, A. J., Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (2004) Nat Med, 10, pp. 145-147

Underiner, T. L., Ruggeri, B., Gingrich, D. E., Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy (2004) Curr Med Chem, 11, pp. 731-745

Sun, J., Wang, D. A., Jain, R. K., Carie, A., Paquette, S., Ennis, E., Blaskovich, M. A., Sebti, S. M., Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors (2005) Oncogene, 24, pp. 4701-4709

Kim, E. S., Serur, A., Huang, J., Manley, C. A., McCrudden, K. W., Frischer, J. S., Soffer, S. Z., Yamashiro, D. J., Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma (2002) Proc Natl Acad Sci U S a, 99, pp. 11399-11404

Niethammer, A. G., Xiang, R., Becker, J. C., Wodrich, H., Pertl, U., Karsten, G., Eliceiri, B. P., Reisfeld, R. A., A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth (2002) Nat Med, 8, pp. 1369-1375

Bae, D. G., Gho, Y. S., Yoon, W. H., Chae, C. B., Arginine-rich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis (2000) J Biol Chem, 275, pp. 13588-13596

D'Andrea, L. D., Iaccarino, G., Fattorusso, R., Sorriento, D., Carannante, C., Capasso, D., Trimarco, B., Pedone, C., Targeting angiogenesis: Structural characterization and biological properties of a de novo engineered VEGF mimicking peptide (2005) Proc Natl Acad Sci U S a, 102, pp. 14215-14220

Giancotti, F. G., Ruoslahti, E., Integrin signaling (1999) Science, 285, pp. 1028-1032

Brooks, P. C., Clark, R. A., Cheresh, D. A., Requirement of vascular integrin alpha v beta 3 for angiogenesis (1994) Science, 264, pp. 569-571

Schlaepfer, D. D., Hauck, C. R., Sieg, D. J., Signaling through focal adhesion kinase (1999) Prog Biophys Mol Biol, 71, pp. 435-478

Longhurst, C. M., Jennings, L. K., Integrin-mediated signal transduction (1998) Cell Mol Life Sci, 54, pp. 514-526

Stupack, D. G., Puente, X. S., Boutsaboualoy, S., Storgard, C. M., Cheresh, D. A., Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins (2001) J Cell Biol, 155, pp. 459-470

Xiong, J. P., Stehle, T., Diefenbach, B., Zhang, R., Dunker, R., Scott, D. L., Joachimiak, A., Arnaout, M. A., Crystal structure of the extracellular segment of integrin alpha Vbeta3 (2001) Science, 294, pp. 339-345

Gottschalk, K. E., Gunther, R., Kessler, H., A three-state mechanism of integrin activation and signal transduction for integrin alpha (v) beta (3) (2002) Chembiochem, 3, pp. 470-473

Pierschbacher, M. D., Ruoslahti, E., Variants of the cell recognition site of fibronectin that retain attachment-promoting activity (1984) Proc Natl Acad Sci U S a, 81, pp. 5985-5988

Albelda, S. M., Buck, C. A., Integrins and other cell adhesion molecules (1990) FASEB J, 4, pp. 2868-2880

Humphries, M. J., The molecular basis and specificity of integrin-ligand interactions (1990) J Cell Sci, 97 (4), pp. 585-592

Miller, W. H., Keenan, R. M., Willette, R. N., Lark, M. W., Identification and in vivo efficacy of small-molecule antagonists of integrin alphavbeta3 (the vitronectin receptor) (2000) Drug Discov Today, 5, pp. 397-408

Marugan, J. J., Manthey, C., Anaclerio, B., Lafrance, L., Lu, T., Markotan, T., Leonard, K. A., Tomczuk, B., Design, synthesis, and biological evaluation of novel potent and selective alphavbeta3/alphavbeta5 integrin dual inhibitors with improved bioavailability. Selection of the molecular core (2005) J Med Chem, 48, pp. 926-934

Goodman, S. L., Holzemann, G., Sulyok, G. A., Kessler, H., Nanomolar small molecule inhibitors for alphav (beta) 6, alphav (beta) 5, and alphav (beta) 3 integrins (2002) J Med Chem, 45, pp. 1045-1051

Dechantsreiter, M. A., Planker, E., Matha, B., Lohof, E., Holzemann, G., Jonczyk, A., Goodman, S. L., Kessler, H., N-Methylated cyclic RGD peptides as highly active and selective alpha (V) beta (3) integrin antagonists (1999) J Med Chem, 42, pp. 3033-3040

Sulyok, G. A., Gibson, C., Goodman, S. L., Holzemann, G., Wiesner, M., Kessler, H., Solid-phase synthesis of a nonpeptide RGD mimetic library: New selective alphavbeta3 integrin antagonists (2001) J Med Chem, 44, pp. 1938-1950

Posey, J. A., Khazaeli, M. B., Delgrosso, A., Saleh, M. N., Lin, C. Y., Huse, W., Lobuglio, A. F., A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer (2001) Cancer Biother Radiopharm, 16, pp. 125-132

Coleman, P. J., Brashear, K. M., Hunt, C. A., Hoffman, W. F., Hutchinson, J. H., Breslin, M. J., McVean, C. A., Ma, B., Non-peptide alpha (v) beta (3) antagonists. identification of potent RGD mimetics incorporating novel beta-amino acids as aspartic acid replacements (2002) Bioorg Med Chem Lett, 3, pp. 31-34

Kumar, C. C., Malkowski, M., Yin, Z., Tanghetti, E., Yaremko, B., Nechuta, T., Varner, J., Armstrong, L., Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha (v) beta3 and alpha (v) beta5 integrin receptor antagonist (2001) Cancer Res, 61, pp. 2232-2238

Van Well, R. M., Overkleeft, H. S., Van Der Marel, G. A., Bruss, D., Thibault, G., De Groot, P. G., Van Boom, J. H., Overhand, M., Solid-phase synthesis of cyclic RGD-furanoid sugar amino acid peptides as integrin inhibitors (2003) Bioorg Med Chem Lett, 13, pp. 331-334

Marugan, J. J., Haslow, K. D., Crysler, C., Design, synthesis, and biochemical evaluation of novel alpha V beta 3 integrin ligands (2004) Bioorg Med Chem Lett, 14, pp. 4553-4555

Eskens, F. A., Dumez, H., Hoekstra, R., Perschl, A., Brindley, C., Bottcher, S., Wynendaele, W., Van Oosterom, A. T., Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumours (2003) Eur J Cancer, 39, pp. 917-926

Gould, R. J., Polokoff, M. A., Friedman, P. A., Huang, T. F., Holt, J. C., Cook, J. J., Niewiarowski, S., Disintegrins: A family of integrin inhibitory proteins from viper venoms (1990) Proc Soc Exp Biol Med, 195, pp. 168-171

Gan, Z. R., Gould, R. J., Jacobs, J. W., Friedman, P. A., Polokoff, M. A., Echistatin. a potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus (1988) J Biol Chem, 263, pp. 19827-19832

Zartler, E. R., Shapiro, M. J., Fragonomics: Fragment-based drug discovery (2005) Curr Opin Chem Biol, 9, pp. 366-370

Yamada, K. M., Even-Ram, S., Integrin regulation of growth factor receptors (2002) Nat Cell Biol, 4, pp. E75-E76

Brooks, P. C., Stromblad, S., Sanders, L. C., Von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., Cheresh, D. A., Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 (1996) Cell, 85, pp. 683-693

Weis, S. M., Cheresh, D. A., Pathophysiological consequences of VEGF-induced vascular permeability (2005) Nature, 437, pp. 497-504

Miller, J. C., Pien, H. H., Sahani, D., Sorensen, A. G., Thrall, J. H., Imaging angiogenesis: Applications and potential for drug development (2005) J Natl Cancer Inst, 97, pp. 172-187



Angiogenesis refers to the process of remodeling the vascular tissue characterized by the branching out of a new blood vessel from a pre-existing vessel. Angiogenesis is particularly active during embryogenesis, while during adult life it is quiescent and limited to particular physiologic phenomena. Recently, the study of molecular mechanisms of angiogenesis has stirred renewed interest due to the recognition of the role played by angiogenesis in several pathologies of significant medical impact, such as cancer and cardiovascular disease, and due to the pharmacologic interest rising from the possibility of modulating these phenomena. Antibodies, peptides and small molecules targeting active endothelial cells represent an innovative tool in therapeutic and diagnostic fields. In this study, we reviewed the literature of peptide and peptidomimetics in angiogenesis and their potential applications. Two specific protein systems, namely the vascular endothelial growth factor and its receptor and integrins, will be discussed in detail. © 2006 Blackwell Munksgaard.
    Tomografia ad emissione di positroni (PET) ad alta risoluzione in modello murino di ischemia miocardica
    Comparison of noninvasive cardiac imaging modalities in patients with myocardial infarction
    Targeted Drug Delivery by integrin avb3 antagonist
    Metals role in angiogenesis
    Peptide modulators of the VEGF-dependent angiogenesis
Nessun risultato.

Contiene: [X]      Estesa     Autori: [X]  Tipo di lavoro: [X]
Data iniziale: Data finale: [X]      Sede: Affiliazione IBB     
    
[Pulisci modulo]


Schutz K, Alecsandru D, Grimbacher B, Haddock J, Bruining A, Driessen G, De Vries E, Van Hagen PM, Hartmann I, Fraioli F, Milito C, Mitrevski M, Quinti I, Serra G, Kelleher P, Loebinger M, Litzman J, Postranecka V, Thon V, Babar J, Condliffe AM, Exley A, Kumararatne D, Screaton N, Jones A, Bondioni MP, Lougaris V, Plebani A, Soresina A, Sirignano C, Spadaro G, Galal N, Gonzalez-granado LI, Dettmer S, Stirling R, Chapel H, Lucas M, Patel S, Farber CM, Meyts I, Banerjee AK, Hackett S, Hurst JR, Warnatz K, Gathmann B, Baumann U
* Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group (5 visite)
J Clin Immunol (ISSN: 0271-9142linking, 1573-2592), 2018 Dec 13; N/D: N/D-N/D.
Impact Factor: 2.654
Dettagli    Esporta in BibTeX    Esporta in EndNote

Supuran CT, Alterio V, Di Fiore A, D'Ambrosio K, Carta F, Monti SM, De Simone G
* Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one (44 visite)
Med Res Rev (ISSN: 1098-1128electronic, 0198-6325linking), 2018 Sep; 38(6): 1799-1836.
Impact Factor: 8.29
Dettagli    Esporta in BibTeX    Esporta in EndNote

Monti M, De Rosa V, Iommelli F, Carriero MV, Terlizzi C, Camerlingo R, Belli S, Fonti R, Di Minno G, Del Vecchio S
* Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins (24 visite)
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic, 1661-6596), 2018 Aug 9; 19(8): N/D-N/D.
Impact Factor: 3.687
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Simone G
* Targeted treatment of anaerobic cancer. Patent evaluation of US2016279084 and US2017056350 (11 visite)
Expert Opinion On Therapeutic Patents (ISSN: 1744-7674electronic, 1354-3776linking), 2018 Jun; N/D: 1-6.
Impact Factor: 4.626
Dettagli    Esporta in BibTeX    Esporta in EndNote

Nappi C, Gaudieri V, Acampa W, Arumugam P, Assante R, Zampella E, Mannarino T, Mainolfi CG, Imbriaco M, Petretta M, Cuocolo A
* Coronary vascular age: An alternate means for predicting stress-induced myocardial ischemia in patients with suspected coronary artery disease (73 visite)
J Nucl Cardiol (ISSN: 1532-6551electronic, 1071-3581linking), 2018 Jan 22; N/D: 1-8.
Impact Factor: 2.811
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petretta M, Acampa W, Assante R, Zampella E, Nappi C, Petretta A, Cuocolo A
* My warranty has expired: I need to be retested (62 visite)
J Nucl Cardiol (ISSN: 1532-6551electronic, 1071-3581linking), 2018 Jan 11; N/D: 1-9.
Impact Factor: 2.811
Dettagli    Esporta in BibTeX    Esporta in EndNote

Nappi C, Nicolai E, Daniele S, Acampa W, Gaudieri V, Assante R, Zampella E, Segreto S, Imbriaco M, Petretta M, Salvatore M, Cuocolo A
* Long-term prognostic value of coronary artery calcium scanning, coronary computed tomographic angiography and stress myocardial perfusion imaging in patients with suspected coronary artery disease (10 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2018; 25(3): 833-841.
Impact Factor: 2.811
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Rosa L, Di Stasi R, D'Andrea LD
* Pro-angiogenic peptides in biomedicine (10 visite)
Arch Biochem Biophys (ISSN: 0003-9861), 2018; 660: 72-86.
Impact Factor: 3.118
Dettagli    Esporta in BibTeX    Esporta in EndNote

Di Stasi R, Diana D, Capasso D, Di Gaetano S, De Rosa L, Celentano V, Isernia C, Fattorusso R, D'Andrea LD
* VEGFR Recognition Interface of a Proangiogenic VEGF-Mimetic Peptide Determined In Vitro and in the Presence of Endothelial Cells by NMR Spectroscopy (10 visite)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2018; 24(44): 11461-11466.
Impact Factor: 5.16
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petrillo S, Chiabrando D, Genova T, Fiorito V, Ingoglia G, Vinchi F, Mussano F, Carossa S, Silengo L, Altruda F, Merlo GR, Munaron L, Tolosano E
* Heme accumulation in endothelial cells impairs angiogenesis by triggering paraptosis (47 visite)
Cell Death Differ (ISSN: 1476-5403electronic, 1350-9047linking), 2017 Dec 11; N/D: N/D-N/D.
Impact Factor: 9.05
Dettagli    Esporta in BibTeX    Esporta in EndNote

Maglio O, Costanzo S, Cercola R, Zambrano G, Mauro M, Battaglia R, Ferrini G, Nastri F, Pavone V, Lombardi A
* A Quartz Crystal Microbalance Immunosensor for Stem Cell Selection and Extraction (60 visite) (PDF 48 visite)
Sensors (ISSN: 1424-8220electronic, 1424-8220linking, 1424-3210), 2017 Nov 28; 17(12): N/D-N/D.
Impact Factor: 2.048
Dettagli    Esporta in BibTeX    Esporta in EndNote

Berisio R, Squeglia F, Ruggiero A
* Editorial: Molecular Scenarios Behind Infectious Diseases (87 visite)
Curr Med Chem (ISSN: 1875-533xelectronic, 0929-8673linking), 2017 Nov 24; 24(36): 3939-3941.
Impact Factor: 3.249
Dettagli    Esporta in BibTeX    Esporta in EndNote

Calvanese L, Foca A, Sandomenico A, Foca G, Caporale A, Doti N, Iaccarino E, Leonardi A, D'Auria G, Ruvo M, Falcigno L
* Structural insights into the interaction of a monoclonal antibody and Nodal peptides by STD-NMR spectroscopy (152 visite)
Bioorg Med Chem (ISSN: 1464-3391electronic, 0968-0896linking), 2017 Oct 28; N/D: N/D-N/D.
Impact Factor: 2.93
Dettagli    Esporta in BibTeX    Esporta in EndNote

Crich SG, Terreno E, Aime S
* Nano-sized and other improved reporters for magnetic resonance imaging of angiogenesis (53 visite)
Adv Drug Deliv Rev (ISSN: 1872-8294electronic, 0169-409xlinking), 2017 Sep 15; 119: 61-72.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Russo R, Rega C, Caporale A, Tonon G, Scaramuzza S, Selis F, Ruvo M, Chambery A
* Ultra-performance liquid chromatography/multiple reaction monitoring mass spectrometry quantification of trastuzumab in human serum by selective monitoring of a specific peptide marker from the antibody complementarity-determining regions (51 visite)
Rapid Commun Mass Spectrom (ISSN: 1097-0231electronic, 0951-4198linking), 2017 Jul 30; 31(14): 1184-1192.
Impact Factor: 2.372
Dettagli    Esporta in BibTeX    Esporta in EndNote

Leiria Campo V, Riul TB, Oliveira Bortot L, Martins-teixeira MB, Fiori Marchiori M, Iaccarino E, Ruvo M, Dias-baruffi M, Carvalho I
* A Synthetic MUC1 Glycopeptide Bearing betaGalNAc-Thr as a Tn Antigen Isomer Induces the Production of Antibodies against Tumor Cells (56 visite)
Chembiochem (ISSN: 1439-7633electronic, 1439-4227linking), 2017 Mar 16; 18(6): 527-538.
Impact Factor: 3.322
Dettagli    Esporta in BibTeX    Esporta in EndNote

Monti M, Iommelli F, De Rosa V, Carriero MV, Miceli R, Camerlingo R, Di Minno G, Del Vecchio S
* Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells (95 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2017 Feb; 12(2): 1-15.
Impact Factor: 3.54
Dettagli    Esporta in BibTeX    Esporta in EndNote

Longo DL, Cutrin JC, Michelotti F, Irrera P, Aime S
* Noninvasive evaluation of renal pH homeostasis after ischemia reperfusion injury by CEST-MRI (75 visite)
Nmr Biomed (ISSN: 0952-3480, 1099-1492electronic, 0952-3480linking), 2017; 30(7): N/D-N/D.
Impact Factor: 3.031
Dettagli    Esporta in BibTeX    Esporta in EndNote

Consolino L, Longo DL, Sciortino M, Dastru W, Cabodi S, Giovenzana GB, Aime S
* Assessing tumor vascularization as a potential biomarker of imatinib resistance in gastrointestinal stromal tumors by dynamic contrast-enhanced magnetic resonance imaging (84 visite)
Gastric Cancer (ISSN: 1436-3305electronic, 1436-3291linking), 2016 Dec 19; N/D: N/D-N/D.
Impact Factor: 5.454
Dettagli    Esporta in BibTeX    Esporta in EndNote

Barone D, Balasco N, Autiero I, Vitagliano L
* The dynamic properties of the Hepatitis C Virus E2 envelope protein unraveled by molecular dynamics (108 visite)
J Biomol Struct Dyn (ISSN: 1538-0254electronic, 0739-1102linking), 2016 Dec; N/D: 1-12.
Impact Factor: 3.123
Dettagli    Esporta in BibTeX    Esporta in EndNote

Accardo A, Del Zoppo L, Morelli G, Condorelli D, Barresi V, Musso N, Spampinato G, Bellia F, Tabbì G, Rizzarelli E
* Liposome antibody-ionophore conjugate antiproliferative activity increases by cellular metallostasis alteration (78 visite)
Med Chem Comm, 2016 Sep; 7: 2364-2367.
Impact Factor: 2.319
Dettagli    Esporta in BibTeX    Esporta in EndNote

Selis F, Focà G, Sandomenico A, Marra C, Di Mauro C, Jotti GS, Scaramuzza S, Politano A, Sanna R, Ruvo M, Tonon G
* Pegylated Trastuzumab Fragments Acquire an Increased in Vivo Stability but Show a Largely Reduced Affinity for the Target Antigen (158 visite) (PDF 167 visite)
Int J Mol Sc (ISSN: 1422-0067electronic, 1422-0067linking, 1661-6596), 2016 Apr 1; 17(4): N/D-N/D.
Impact Factor: 3.226
Dettagli    Esporta in BibTeX    Esporta in EndNote

La Mendola D, Arnesano F, Hansson O, Giacomelli C, Calo V, Mangini V, Magrì A, Bellia F, Trincavelli ML, Martini C, Natile G, Rizzarelli E
* Copper binding to naturally occurring, lactam form of angiogenin differs from that to recombinant protein, affecting their activity (112 visite)
Metallomics (ISSN: 1756-591xelectronic, 1756-5901linking), 2016 Jan 20; 8(1): 118-124.
Impact Factor: 3.975
Dettagli    Esporta in BibTeX    Esporta in EndNote

Consolino L, Longo DL, Dastrù W, Cutrin JC, Dettori D, Lanzardo S, Oliviero S, Cavallo F, Aime S
* Functional imaging of the angiogenic switch in a transgenic mouse model of human breast cancer by dynamic contrast enhanced magnetic resonance imaging (89 visite)
International Journal Of Cancer (ISSN: 0020-7136), 2016; N/D: N/D-N/D.
Impact Factor: 6.513
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ribaldone DG, Fagoonee S, Hickman I, Altruda F, Saracco GM, Pellicano R
* Helicobacter pylori infection and ischemic heart disease: Could experimental data lead to clinical studies? (14 visite)
Minerva Cardioangiol (ISSN: 0026-4725), 2016; 64(6): 686-696.
Impact Factor: 0.481
Dettagli    Esporta in BibTeX    Esporta in EndNote

Bogdanovich S, Kim Y, Mizutani T, Yasuma R, Tudisco L, Cicatiello V, Bastos-carvalho A, Kerur N, Hirano Y, Baffi JZ, Tarallo V, Li S, Yasuma T, Arpitha P, Fowler BJ, Wright CB, Apicella I, Greco A, Brunetti A, Ruvo M, Sandomenico A, Nozaki M, Ijima R, Kaneko H, Ogura Y, Terasaki H, Ambati BK, Leusen JH, Langdon WY, Clark MR, Armour KL, Bruhns P, Verbeek JS, Gelfand BD, De Falco S, Ambati J
* Human IgG1 antibodies suppress angiogenesis in a target-independent manner (271 visite)
Signal Transduct Target Ther (ISSN: 2059-3635print), 2016; 1: N/D-N/D.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Nappi C, Gaudieri V, Petretta M, Cuocolo A
* Noninvasive Cardiac Imaging in Obesity: Challenges and Opportunities (14 visite)
Curr Cardiovasc Imaging Rep (ISSN: 1941-9066), 2016; 9(9): N/D-N/D.
Impact Factor:
Dettagli    Esporta in BibTeX    Esporta in EndNote

Di Stasi R, De Rosa L, Romanelli A, D'Andrea LD
* Peptides Interacting with Growth Factor Receptors Regulating Angiogenesis (86 visite)
Frontiers In Medicinal Chemistry, 2016; 9: 130-160.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Grasso G, Santoro AM, Magrì A, La Mendola D, Tomasello MF, Zimbone S, Rizzarelli E
* The Inorganic Perspective of VEGF: Interactions of Cu2 + with Peptides Encompassing a Recognition Domain of the VEGF Receptor (143 visite)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 2016; 159: 149-158.
Impact Factor: 3.348
Dettagli    Esporta in BibTeX    Esporta in EndNote

Strizzi L, Sandomenico A, Margaryan NV, Foca A, Sanguigno L, Bodenstine TM, Chandler GS, Reed DW, Gilgur A, Seftor EA, Seftor RE, Khalkhali-ellis Z, Leonardi A, Ruvo M, Hendrix MJ
* Effects of a novel Nodal-targeting monoclonal antibody in melanoma (220 visite) (PDF 128 visite)
Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2015 Oct 27; 6(33): 34071-34086.
Impact Factor: 5.008
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pignataro G, Ziaco B, Tortiglione A, Gala R, Cuomo O, Vinciguerra A, Lapi D, Mastantuono T, Anzilotti S, D'Andrea LD, Pedone C, Di Renzo G, Annunziato L, Cataldi M
* Neuroprotective Effect of VEGF-Mimetic Peptide QK in Experimental Brain Ischemia Induced in Rat by Middle Cerebral Artery Occlusion (114 visite)
Acs Chem Neurosci (ISSN: 1948-7193electronic, 1948-7193linking), 2015 Sep 16; 6(9): 1517-1525.
Impact Factor: 4.348
Dettagli    Esporta in BibTeX    Esporta in EndNote

Foca A, Sanguigno L, Foca G, Strizzi L, Iannitti R, Palumbo R, Hendrix MJ, Leonardi A, Ruvo M, Sandomenico A
* New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding (285 visite) (PDF 165 visite)
Int J Mol Sc (ISSN: 1422-0067electronic, 1422-0067linking, 1661-6596), 2015 Sep 7; 16(9): 21342-21362.
Impact Factor: 3.257
Dettagli    Esporta in BibTeX    Esporta in EndNote

Calce E, Monfregola L, Saviano M, De Luca S
* HER2-mediated anticancer drug delivery: strategies to prepare targeting ligands highly specific for the receptor (265 visite)
Curr Med Chem (ISSN: 1875-533xelectronic, 0929-8673linking), 2015 May 20; 22(21): 2525-2538.
Impact Factor: 3.455
Dettagli    Esporta in BibTeX    Esporta in EndNote

Giacomelli C, Trincavelli ML, Satriano C, Hansson O, La Mendola D, Rizzarelli E, Martini C
* Copper (II) ions modulate Angiogenin activity in human endothelial cells (125 visite)
Int J Biochem Cell Biol International Journal Of Biochemistry And Cell Biology (ISSN: 1878-5875, 1357-7272, 1357-2725), 2015 Mar; 60: 185-196.
Impact Factor: 3.905
Dettagli    Esporta in BibTeX    Esporta in EndNote

Calvanese L, Falcigno L, D'Auria G
* Essential Dynamics Analysis Captures the Concerted Motion of the Integrin-Binding Site in Jerdostatin, an RTS Disintegrin (126 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2015 Mar; 103(3): 158-166.
Impact Factor: 2.248
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ciccarelli M, Rusciano MR, Sorriento D, Maione AS, Soprano M, Iaccarino G, Illario M
* Messages from the Border: Novel Insights in Signal Transduction Pathways Involved in Tumor Invasion and Metastasis (108 visite)
Journal Of Cancer Therapy (ISSN: 2151-1934), 2015 Feb 11; 6: 199-212.
Impact Factor: 0.56
Dettagli    Esporta in BibTeX    Esporta in EndNote

Diana D, Russomanno A, De Rosa L, Di Stasi R, Capasso D, Di Gaetano S, Romanelli A, Russo L, D'Andrea LD, Fattorusso R
* Functional Binding Surface Of A Beta-Hairpin Vegf Receptor Targeting Peptide Determined By Nmr Spectroscopy In Living Cells (147 visite)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2015 Jan 2; 21(1): 91-95.
Impact Factor: 5.771
Dettagli    Esporta in BibTeX    Esporta in EndNote

Longo DL, Dastrù W, Consolino L, Espak M, Arigoni M, Cavallo F, Aime S
* Cluster analysis of quantitative parametric maps from DCE-MRI: Application in evaluating heterogeneity of tumor response to antiangiogenic treatment (251 visite)
Magn Reson Imaging (ISSN: 0730-725x), 2015; 33(6): 725-736.
Impact Factor: 1.98
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cicatiello V, Apicella I, Tudisco L, Tarallo V, Formisano L, Sandomenico A, Kim Y, Bastos-Carvalho A, Orlandi A, Ambati J, Ruvo M, Bianco R, de Falco S
* Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models (127 visite)
Oncotarget (ISSN: 1949-2553, 1949-2553electronic, 1949-2553linking), 2015; 6(12): 10563-10576.
Impact Factor: 5.008
Dettagli    Esporta in BibTeX    Esporta in EndNote

Perri F, Pacelli R, Della Vittoria Scarpati G, Cella L, Giuliano M, Caponigro F, Pepe S
* Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications (143 visite)
Head & Neck (ISSN: 1043-3074), 2015; 37(5): 763-770.
Impact Factor: 2.76
Dettagli    Esporta in BibTeX    Esporta in EndNote

Marini C, Acampa W, Bauckneht M, Daniele S, Capitanio S, Cantoni V, Fiz F, Zampella E, Dib B, Assante R, Bruzzi P, Sambuceti G, Cuocolo A
* Added prognostic value of ischaemic threshold in radionuclide myocardial perfusion imaging: a common-sense integration of exercise tolerance and ischaemia severity (211 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2014 Dec 5; 42(5): 750-760.
Impact Factor: 5.383
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petretta M, Acampa W, Cuocolo A
* Cardiovascular risk stratification in diabetic patients: is all in METS? (144 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2014 Dec; 21(6): 1144-1147.
Impact Factor: 2.942
Dettagli    Esporta in BibTeX    Esporta in EndNote

Moccia M, Erro R, Montella S, Carotenuto A, Pappata S, Orefice G
* Diagnostic challenges of Parkinsonism occurring in multiple sclerosis (77 visite)
Acta Neurol Belg (ISSN: 0300-9009), 2014 Oct 12; 115(3): 513-515.
Impact Factor: 0.894
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lanzillo R, Liuzzi R, Vallefuoco L, Moccia M, Amato L, Vacca G, Vacchiano V, Portella G, Brescia Morra V
* JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level (95 visite)
Ther Clin Risk Manag (ISSN: 1178-203x, 1176-6336linking), 2014 Oct 9; 10: 807-814.
Impact Factor: 1.469
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gargiulo S, Petretta MP, Greco A, Panico M, Larobina M, Gramanzini M, Schiattarella GG, Esposito G, Petretta M, Brunetti A, Cuocolo A
* Genetic deletion in uncoupling protein 3 augments 18F-fluorodeoxyglucose cardiac uptake in the ischemic heart (145 visite)
Bmc Cardiovasc Disord (ISSN: 1471-2261), 2014 Sep 8; 14(1): 98-98.
Impact Factor: 1.878
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gallicchio R, Mansueto G, Simeon V, Nardelli A, Guariglia R, Capacchione D, Soscia E, Pedicini P, Gattozzi D, Musto P, Storto G
* F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma (112 visite)
European Journal Of Haematology (ISSN: 0902-4441, 0902-4441linking), 2014 May; 92(5): 382-389.
Impact Factor: 2.066
Dettagli    Esporta in BibTeX    Esporta in EndNote

Carriero MV, Bifulco K, Minopoli M, Lista L, Maglio O, Mele L, Di Carluccio G, De Rosa M, Pavone V
* UPARANT: a urokinase receptor-derived peptide inhibitor of VEGF-driven angiogenesis with enhanced stability and in vitro and in vivo potency (142 visite)
Mol Cancer Ther Molecular Cancer Therapeutics (ISSN: 1538-8514electronic, 1535-7163linking), 2014 May; 13(5): 1092-1104.
Impact Factor: 5.683
Dettagli    Esporta in BibTeX    Esporta in EndNote

Accardo A, Aloj L, Aurilio M, Morelli G, Tesauro D
* Receptor binding peptides for target-selective delivery of nanoparticles encapsulated drugs (199 visite)
Int J Nanomed (ISSN: 1176-9114, 1178-2013, 1178-2013electronic), 2014 Mar 27; 9(1): 1537-1557.
Impact Factor: 4.383
Dettagli    Esporta in BibTeX    Esporta in EndNote

Musumeci D, Roviello GN, Montesarchio D
* An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies (174 visite)
Pharmacology & Therapeutics (ISSN: 0163-7258), 2014 Mar; 141(3): 347-357.
Impact Factor: 9.723
Dettagli    Esporta in BibTeX    Esporta in EndNote

Rai M, Kon K, Ingle A, Duran N, Galdiero S, Galdiero M
* Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects (355 visite)
Applied Microbiology And Biotechnology (ISSN: 0175-7598), 2014 Mar; 98(5): 1951-1961.
Impact Factor: 3.337
Dettagli    Esporta in BibTeX    Esporta in EndNote

Nold-Petry CA, Rudloff I, Baumer Y, Ruvo M, Marasco D, Botti P, Farkas L, Cho SX, Zepp JA, Azam T, Dinkel H, Palmer BE, Boisvert WA, Cool CD, Taraseviciene-Stewart L, Heinhuis B, Joosten LA, Dinarello CA, Voelkel NF, Nold MF
* IL-32 Promotes Angiogenesis (197 visite)
Journal Of Immunology (ISSN: 0022-1767), 2014 Jan 15; 192(2): 589-602.
Impact Factor: 4.922
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Rosa L, Diana D, Basile A, Russomanno A, Isernia C, Turco MC, Fattorusso R, D'Andrea LD
* Design, Structural And Biological Characterization Of A Vegf Inhibitor Beta-Hairpin-Constrained Peptide (142 visite)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 1768-3254electronic), 2014; 73: 210-216.
Impact Factor: 3.447
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petretta M, Acampa W, Evangelista L, Daniele S, Zampella E, Assante R, Nappi C, Cantoni V, Fiumara G, Cuocolo A
* Reclassification of cardiovascular risk by myocardial perfusion imaging in diabetic patients with abnormal resting electrocardiogram (139 visite)
Nutrition (ISSN: 0939-4753, 1590-3729electronic), 2014; 24(6): 588-593.
Impact Factor: 3.323
Dettagli    Esporta in BibTeX    Esporta in EndNote

Dynkevich Y, Rother KI, Whitford I, Qureshi S, Galiveeti S, Szulc AL, Danoff A, Breen TL, Kaviani N, Shanik MH, LeRoith D, Vigneri R, Koch CA, Roth J
* Tumors, IGF-2, and Hypoglycemia: Insights From the Clinic, the Laboratory, and the Historical Archive (690 visite)
Endocrine Reviews (ISSN: 0163-769x), 2013 Dec; 34(6): 798-826.
Impact Factor: 19.358
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ferro A, Petretta M, Acampa W, Fiumara G, Daniele S, Petretta MP, Cantoni V, Cuocolo A
* Post-stress left ventricular ejection fraction drop in patients with diabetes: A gated myocardial perfusion imaging study (123 visite)
Bmc Cardiovasc Disord (ISSN: 1471-2261), 2013 Nov 14; 13: 99-99.
Impact Factor: 1.5
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petretta M, Acampa W, Daniele S, Petretta MP, Plaitano M, Cuocolo A
* Transient ischemic dilation in patients with diabetes mellitus: prognostic value and effect on clinical outcome after coronary revascularization (107 visite)
Circ Cardiovasc Imaging (ISSN: 1942-0080, 1941-9651), 2013 Nov; 6(6): 908-915.
Impact Factor: 1.783
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petretta M, Fiumara G, Petretta MP, Cuocolo A
* Detection of silent myocardial ischemia: is it clinically relevant? (107 visite)
J Nucl Cardiol (ISSN: 1532-6551, 1071-3581, 1532-6551electronic), 2013 Oct; 20(5): 707-710.
Impact Factor: 2.645
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mancini M, Greco A, Salvatore G, Liuzzi R, Di Maro G, Vergara E, Chiappetta G, Pasquinelli R, Brunetti A, Salvatore M
* Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice (238 visite)
Bmc Med Imaging (ISSN: 1471-2342), 2013 Sep 12; 13(1): 31-31.
Impact Factor: 0.983
Dettagli    Esporta in BibTeX    Esporta in EndNote

Acampa W, Petretta MP, Daniele S, Perrone-Filardi P, Petretta M, Cuocolo A
* Myocardial perfusion imaging after coronary revascularization: A clinical appraisal (141 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Sep; 40(8): 1275-1282.
Impact Factor: 5.217
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ruggiero D, Paolillo S, Ratta GD, Mariniello A, Formisano T, Pellegrino AM, Filardi PP
* [Endothelial function as a marker of pre-clinical atherosclerosis: assessment techniques and clinical implications] (97 visite)
Monaldi Arch Chest Dis Card Ser (ISSN: 1122-0643, 1122-0643print), 2013 Sep; 80(3): 106-110.
Impact Factor: 7.132
Dettagli    Esporta in BibTeX    Esporta in EndNote

Russo Krauss I, Merlino A, Vergara A, Sica F
* An overview of biological macromolecule crystallization (181 visite)
Int J Mol Sc (ISSN: 1422-0067, 1661-6596, 1422-0067electronic), 2013 May 31; 14(6): 11643-11691.
Impact Factor: 2.339
Dettagli    Esporta in BibTeX    Esporta in EndNote

Perrino C, Schiattarella GG, Sannino A, Pironti G, Petretta MP, Cannavo A, Gargiulo G, Ilardi F, Magliulo F, Franzone A, Carotenuto G, Serino F, Altobelli GG, Cimini V, Cuocolo A, Lombardi A, Goglia F, Indolfi C, Trimarco B, Esposito G
* Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure (123 visite)
J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2013 May 20; 2(3): e000086-e000086.
Impact Factor: 2.882
Dettagli    Esporta in BibTeX    Esporta in EndNote

Marotta V, Ramundo V, Camera L, Del Prete M, Fonti R, Esposito R, Palmieri G, Salvatore M, Vitale M, Colao A, Faggiano A
* Sorafenib in advanced iodine-refractory differentiated thyroid cancer: Efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET (195 visite)
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic), 2013 May; 78(5): 760-767.
Impact Factor: 3.353
Dettagli    Esporta in BibTeX    Esporta in EndNote

Acampa W, Petretta M, Daniele S, Del Prete G, Assante R, Zampella E, Cuocolo A
* Incremental prognostic value of stress myocardial perfusion imaging in asymptomatic diabetic patients (109 visite)
Atherosclerosis (ISSN: 0021-9150, 1879-1484), 2013 Apr; 227(2): 307-312.
Impact Factor: 3.971
Dettagli    Esporta in BibTeX    Esporta in EndNote

Diana D, Di Stasi R, De Rosa L, Isernia C, D'Andrea LD, Fattorusso R
* Structural investigation of the VEGF receptor interaction with a helical antagonist peptide (135 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2013 Apr; 19(4): 214-219.
Impact Factor: 1.862
Dettagli    Esporta in BibTeX    Esporta in EndNote

Greco A, Fiumara G, Gargiulo S, Gramanzini M, Brunetti A, Cuocolo A
* High-resolution positron emission tomography/computed tomography imaging of the mouse heart (184 visite)
Exp Physiol Experimental Physiology (ISSN: 1469-445x, 0958-0670), 2013 Mar; 98(3): 645-651.
Impact Factor: 2.871
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pisano M, De Paola I, Nieddu V, Sassu I, Cossu S, Galleri G, Del Gatto A, Budroni M, Cossu A, Saviano M, Palmieri G, Zaccaro L, Rozzo C
* In vitro activity of the alphavbeta3 integrin antagonist RGDechi-hCit on malignant melanoma cells (111 visite)
Anticancer Res (ISSN: 0250-7005, 0250-0700, 1791-7530electronic), 2013 Mar; 33(3): 871-879.
Impact Factor: 1.045
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petretta M, Acampa W, Daniele S, Petretta MP, Nappi C, Assante R, Zampella E, Costanzo P, Perrone-Filardi P, Cuocolo A
* Transient ischemic dilation in SPECT myocardial perfusion imaging for prediction of severe coronary artery disease in diabetic patients (133 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2013 Feb; 20(1): 45-52.
Impact Factor: 2.645
Dettagli    Esporta in BibTeX    Esporta in EndNote

Scalia M, Satriano C, Greca R, Stella AM, Rizzarelli E, Spina-Purrello V
* PARP-1 inhibitors DPQ and PJ-34 negatively modulate proinflammatory commitment of human glioblastoma cells (149 visite)
Neurochemical Research (ISSN: 1573-6903, 0364-3190), 2013 Jan; 38(1): 50-58.
Impact Factor: 2.551
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Giudice R, Monti DM, Truppo E, Arciello A, Supuran CT, De Simone G, Monti SM
* Human Carbonic Anhydrase Vii Protects Cells From Oxidative Damage (122 visite)
Biol Chem Biological Chemistry (ISSN: 1431-6730, 1431-1673, 1437-4315), 2013; 394(10): 1343-1348.
Impact Factor: 2.689
Dettagli    Esporta in BibTeX    Esporta in EndNote

Galasso G, De Rosa R, Ciccarelli M, Sorriento D, Del Giudice C, Strisciuglio T, De Biase C, Luciano R, Piccolo R, Pierri A, Di Gioia G, Prevete N, Trimarco B, Piscione F, Iaccarino G
* β2-adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis (105 visite)
Circ Res (ISSN: 0009-7330, 1524-4571electronic, 0009-7330linking), 2013; 112(7): 1026-1034.
Impact Factor: 11.089
Dettagli    Esporta in BibTeX    Esporta in EndNote

Kaprelyants AS, Mukamolova GV, Ruggiero A, Makarov VA, Demina GR, Shleeva MO, Potapov VD, Shramko PA
* Resuscitation-promoting Factors (Rpf): In Search of Inhibitors (125 visite)
Protein Pept Lett (ISSN: 0929-8665, 1875-5305), 2012 Oct; 19(10): 1026-1034.
Impact Factor: 1.994
Dettagli    Esporta in BibTeX    Esporta in EndNote

Tagliamonte M, Marasco D, Ruggiero A, de Stradis A, Tornesello ML, Totrov M, Buonaguro FM, Buonaguro L
* HIV p24 as Scaffold for Presenting Conformational HIV Env Antigens (147 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2012 Sep 17; 7(8): N/D-N/D.
Impact Factor: 3.73
Dettagli    Esporta in BibTeX    Esporta in EndNote

Finetti F, Basile A, Capasso D, Di Gaetano S, Di Stasi R, Pascale M, Turco CM, Ziche M, Morbidelli L, D'Andrea LD
* Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis (167 visite)
Biochem Pharmacol Biochemical Pharmacology (ISSN: 0006-2952, 1873-2968), 2012 Sep 1; 84(3): 303-311.
Impact Factor: 4.576
Dettagli    Esporta in BibTeX    Esporta in EndNote

Magrì A, D'Alessandro F, Di Stefano DA, Campagna T, Pappalardo G, Impellizzeri G, La Mendola D
* Copper(ii) Coordination Properties Of The Integrin Ligand Sequence Phsrn And Its New Beta-Cyclodextrin Conjugates (160 visite)
Journal Of Inorganic Biochemistry, 2012 Sep; 113: 15-24.
Impact Factor: 3.444
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caraci F, Battaglia G, Sortino MA, Spampinato S, Molinaro G, Copani A, Nicoletti F, Bruno V
* Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic? (153 visite)
Neurochem Int (ISSN: 0197-0186), 2012 Sep; 61(4): 559-565.
Impact Factor: 2.659
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ziaco B, Diana D, Capasso D, Palumbo R, Celentano V, Di Stasi R, Fattorusso R, D'Andrea LD
* C-terminal truncation of Vascular Endothelial Growth Factor mimetic helical peptide preserves structural and receptor binding properties (131 visite)
Biochem Biophys Res Commun (ISSN: 0006-291x), 2012 Jul 27; 424(2): 290-294.
Impact Factor: 2.406
Dettagli    Esporta in BibTeX    Esporta in EndNote

Poletto M, Di Loreto C, Marasco D, Poletto E, Puglisi F, Damante G, Tell G
* Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers (109 visite)
Biochemical And Biophysical Research Communications (ISSN: 0006-291x), 2012 Jul 20; 424(1): 34-39.
Impact Factor: 2.406
Dettagli    Esporta in BibTeX    Esporta in EndNote

Marciano C, Galderisi M, Gargiulo P, Acampa W, D'Amore C, Esposito R, Capasso E, Savarese G, Casaretti L, Lo Iudice F, Esposito G, Rengo G, Leosco D, Cuocolo A, Perrone-Filardi P
* Effects of type 2 diabetes mellitus on coronary microvascular function and myocardial perfusion in patients without obstructive coronary artery disease (176 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2012 Jul; 39(7): 1199-1206.
Impact Factor: 5.114
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pedicini P, Caivano R, Jereczek-Fossa BA, Strigari L, Vischioni B, Alterio D, Cremonesi M, Botta F, Nappi A, Improta G, Storto G, Benassi M, Orecchia R
* Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors (106 visite)
Theor Biol Med Model (ISSN: 1742-4682), 2012 Jun 19; 9(1): 23-23.
Impact Factor: 1.461
Dettagli    Esporta in BibTeX    Esporta in EndNote

La Mendola D, Magrì A, Santoro AM, Nicoletti VG, Rizzarelli E
* Copper(II) interaction with peptide fragments of histidine-proline-rich glycoprotein: Speciation, stability and binding details (119 visite)
J Chem Res (ISSN: 1873-3344, 0162-0134, 0162-0134print), 2012 Jun; 111: 59-69.
Impact Factor: 3.197
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cella L, Conson M, Caterino M, De Rosa N, Liuzzi R, Picardi M, Grimaldi F, Solla R, Farella A, Salvatore M, Pacelli R
* Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma (163 visite) (PDF 132 visite)
Int J Radiat Oncol Biol Phys (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2012 Apr 1; 82(5): 1802-1808.
Impact Factor: 4.524
Dettagli    Esporta in BibTeX    Esporta in EndNote

Perrone-filardi P, Cuocolo A, Dellegrottaglie S
Myocardial perfusion imaging in very elderly patients with suspected coronary artery disease: never too late! (121 visite)
J Nucl Cardiol (ISSN: 1532-6551, 1071-3581, 1532-6551electronic), 2012 Apr; 19(2): 224-226.
Impact Factor: 2.847
Dettagli    Esporta in BibTeX    Esporta in EndNote

Monti SM, Supuran CT, De Simone G
* Carbonic anhydrase IX as a target for designing novel anticancer drugs (185 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2012 Feb; 19(6): 821-830.
Impact Factor: 4.07
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pilla P, Sandomenico A, Malachovsk V, Borriello A, Giordano M, Cutolo A, Ruvo M, Cusano A
* A protein-based biointerfacing route toward label-free immunoassays with long period gratings in transition mode (129 visite)
Biosens Bioelectron (ISSN: 0956-5663, 1873-4235electronic, 0956-5663linking), 2012 Jan 15; 31(1): 486-491.
Impact Factor: 5.437
Dettagli    Esporta in BibTeX    Esporta in EndNote

Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G
* CaMK4 gene deletion induces hypertension (105 visite)
J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D.
Impact Factor: 2.882
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sorriento D, Santulli G, Del Giudice C, Anastasio A, Trimarco B, Iaccarino G
* Endothelial cells are able to synthesize and release catecholamines both in vitro and in vivo (116 visite)
Hypertensionhypertension (ISSN: 0194-911x), 2012; 60(1): 129-136.
Impact Factor: 6.873
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fusco A, Santulli G, Sorriento D, Cipolletta E, Garbi C, Dorn GW, Trimarco B, Feliciello A, Iaccarino G
* Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis (114 visite)
Cell Signal Cellular Signalling (ISSN: 0898-6568), 2012; 24(2): 468-475.
Impact Factor: 4.304
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gargiulo S, Greco A, Gramanzini M, Petretta MP, Ferro A, Larobina M, Panico M, Brunetti A, Cuocolo A
* PET/CT imaging in mouse models of myocardial ischemia (270 visite)
J Biomed Biotechnol (ISSN: 1110-7251, 1110-7243), 2012; 2012: 541872-541872.
Impact Factor: 2.88
Dettagli    Esporta in BibTeX    Esporta in EndNote

Diana D, Basile A, De Rosa L, Di Stasi R, Auriemma S, Arra C, Pedone C, Turco MC, Fattorusso R, D'Andrea LD
* Beta-Hairpin Peptide That Targets Vascular Endothelial Growth Factor (vegf) Receptors: Design, Nmr Characterization, And Biological Activity (161 visite)
J Biol Chem Journal Of Biological Chemistry (ISSN: 1083-351x, 0021-9258), 2011 Dec 2; 286(48): 41680-41691.
Impact Factor: 4.773
Dettagli    Esporta in BibTeX    Esporta in EndNote

Casella V, Avitabile G, Segreto S, Mainenti PP
* CT findings in a mixed-type acute gastric volvulus (81 visite)
Emergency Radiology (ISSN: 1070-3004), 2011 Dec; 18(6): 483-486.
Impact Factor: 6.214
Dettagli    Esporta in BibTeX    Esporta in EndNote

Daniele S, Nappi C, Acampa W, Storto G, Pellegrino T, Ricci F, Xhoxhi E, Porcaro F, Petretta M, Cuocolo A
* Incremental prognostic value of coronary flow reserve assessed with single-photon emission computed tomography (93 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2011 Sep; 18(4): 612-619.
Impact Factor: 2.668
Dettagli    Esporta in BibTeX    Esporta in EndNote

Bellia F, Vecchio G, Cuzzocrea S, Calabrese V, Rizzarelli E
* Neuroprotective features of carnosine in oxidative driven diseases (132 visite)
Molecular Aspects Of Medicine (ISSN: 1872-9452, 0098-2997), 2011 Sep; 32(4-6): 258-266.
Impact Factor: 9.97
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ruvo M, Sandomenico A, Tudisco L, De Falco S
* Branched peptides for the modulation of protein-protein interactions: More arms are better than one? (184 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2011 Jun; 18(16): 2429-2437.
Impact Factor: 4.859
Dettagli    Esporta in BibTeX    Esporta in EndNote

Acampa W, Di Taranto MD, Morgante A, Salvatore B, Evangelista L, Ricci F, Costanzo P, De Sisto E, Filardi PP, Petretta M, Fortunato G, Cuocolo A
* C-reactive protein levels are associated with paraoxonase polymorphism L55M in patients undergoing cardiac SPECT imaging (145 visite)
Scand J Clin Lab Invest (ISSN: 0036-5513, 1502-7686), 2011 May; 71(3): 179-184.
Impact Factor: 1.156
Dettagli    Esporta in BibTeX    Esporta in EndNote

Perrone-filardi P, Dellegrottaglie S, Rudd JH, Costanzo P, Marciano C, Vassallo E, Marsico F, Ruggiero D, Petretta MP, Chiariello M, Cuocolo A
* Molecular imaging of atherosclerosis in translational medicine (183 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2011 May; 38(5): 969-975.
Impact Factor: 4.991
Dettagli    Esporta in BibTeX    Esporta in EndNote

Troise F, Monti M, Merlino A, Cozzolino F, Fedele C, Russo Krauss I, Sica F, Pucci P, D'Alessio G, De Lorenzo C
* A novel ErbB2 epitope targeted by human antitumor immunoagents (122 visite)
Febs Journal (ISSN: 1742-464x), 2011 Apr; 278(7): 1156-1166.
Impact Factor: 3.79
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lanzillo R, Orefice G, Prinster A, Ventrella G, Liuzzi R, Scarano V, Florio C, Vacca G, Brunetti A, Alfano B, Brescia Morra V, Bonavita V
* Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy (93 visite) (PDF 114 visite)
Neurol Sci (ISSN: 1590-1874, 1590-3478), 2011 Apr; 32(2): 287-292.
Impact Factor: 1.315
Dettagli    Esporta in BibTeX    Esporta in EndNote

Basile A, Del Gatto A, Diana D, Di Stasi R, Falco A, Festa M, Rosati A, Barbieri A, Franco R, Arra C, Pedone C, Fattorusso R, Turco MC, D'Andrea LD
* Characterization of a designed vascular endothelial growth factor receptor antagonist helical peptide with antiangiogenic activity in vivo (134 visite)
J Med Chem (ISSN: 1520-4804, 0022-2623, 0022-2623print), 2011 Mar 10; 54(5): 1391-1400.
Impact Factor: 5.248
Dettagli    Esporta in BibTeX    Esporta in EndNote

Manganelli F, Spadafora M, Varrella P, Peluso G, Sauro R, Di Lorenzo E, Rosato G, Daniele S, Cuocolo A
* Addition of atropine to submaximal exercise stress testing in patients evaluated for suspected ischaemia with SPECT imaging: a randomized, placebo-controlled trial (128 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2011 Feb; 38(2): 245-251.
Impact Factor: 4.991
Dettagli    Esporta in BibTeX    Esporta in EndNote

Santulli G, Basilicata MF, De Simone M, Del Giudice C, Anastasio A, Sorriento D, Saviano M, Del Gatto A, Trimarco B, Pedone C, Zaccaro L, Iaccarino G
* Evaluation of the anti-angiogenic properties of the new selective alphaVbeta3 integrin antagonist RGDechiHCit (120 visite)
J Transl Med Journal Of Translational Medicine (ISSN: 1479-5876electronic), 2011 Jan 13; 9: 7-7.
Impact Factor: 3.474
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ciccarelli M, Sorriento D, Cipolletta E, Santulli G, Fusco A, Zhou R-H, Eckhart AD, Peppel K, Koch WJ, Trimarco B, Iaccarino G
* Impaired neoangiogenesis in β2-adrenoceptor gene-deficient mice: Restoration by intravascular human β2-adrenoceptor gene transfer and role of NFkB and CREB transcription factors (113 visite)
Br J Pharmacol British Journal Of Pharmacology (ISSN: 0007-1188), 2011; 162(3): 712-721.
Impact Factor: 4.409
Dettagli    Esporta in BibTeX    Esporta in EndNote

Dettin M, Ghezzo F, Conconi MT, Urbani L, D'Auria G, Falcigno L, Guidolin D, Nico B, Ribatti D, Di Bello C, Parnigotto PP
* In vitro and in vivo pro-angiogenic effects of thymosin-β4-derived peptides (167 visite)
Cell Immunol (ISSN: 0008-8749), 2011; 271(2): 299-307.
Impact Factor: 1.974
Dettagli    Esporta in BibTeX    Esporta in EndNote

La Mendola D, Magrì A, Vagliasindi LI, Hansson Ö, Bonomo RP, Rizzarelli E
* Copper(II) complex formation with a linear peptide encompassing the putative cell binding site of angiogenin (110 visite)
Dalton Trans (ISSN: 1477-9234, 1477-9226, 1477-9234electronic), 2010 Nov 28; 39(44): 10678-10684.
Impact Factor: 3.647
Dettagli    Esporta in BibTeX    Esporta in EndNote

Acampa W, Evangelista L, Daniele S, Xhoxhi E, De Rimini ML, Cittanti C, Marranzano F, Spadafora M, Baldari S, Mansi L, Petretta M, Cuocolo A
* Impact of Inducible Ischemia by SPECT Imaging on Cardiac Risk Assessment in Diabetic Patients: Results of a Prospective, Multicenter Trial (75 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Oct; 37: N/D-N/D.
Impact Factor: 5.036
Dettagli    Esporta in BibTeX    Esporta in EndNote

D'Andrea LD, Romanelli A, Di Stasi R, Pedone C
* Bioinorganic aspects of angiogenesis (119 visite)
Dalton Trans (ISSN: 1477-9234, 1477-9226, 1477-9234electronic), 2010 Sep 7; 39(33): 7625-7636.
Impact Factor: 3.647
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sirignano C
Ct Diagnostics Of Pulmonary Desease In Patients With Antibody Deficient (81 visite)
Xiv Th Meeting Of The European Society Fo Immunodeficiencies, 2010 Sep; N/D: N/D-N/D.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Spadafora M, Varrella P, Acampa W, Spirito M, Nappi C, Mansi L, Miletto P, Rosato G, Cuocolo A
* Direct imaging of viable myocardium by gated SPECT in patients with ischaemic left ventricular dysfunction (99 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Sep; 37(9): 1730-1735.
Impact Factor: 5.036
Dettagli    Esporta in BibTeX    Esporta in EndNote

Palmieri C, Falcone C, Iaccino E, Tuccillo FM, Gaspari M, Trimboli F, De Laurentiis A, Luberto L, Pontoriero M, Pisano A, Vecchio E, Fierro O, Panico M, Larobina M, Gargiulo S, Costa N, Dal Piaz F, Schiavone M, Arra C, Giudice A,  Palma G, Barbieri A, Quinto I, Scala G
* In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder (152 visite)
Blood (ISSN: 0006-4971, 0006-6497, 0390-6078), 2010 Jul 15; 116(2): 226-238.
Impact Factor: 10.558
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Pizzuti LM, Lettieri A, Salvatore M
* PET/CT in cancer research: From preclinical to clinical applications (172 visite)
Contrast Media Mol Imaging (ISSN: 1555-4309, 1555-4309linking), 2010 Jul; 5(4): 190-200.
Impact Factor: 4.02
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gautier B, Goncalves V, Diana D, Di Stasi R, Teillet F, Lenoir C, Huguenot F, Garbay C, Fattorusso R, D'Andrea LD, Vidal M, Inguimbert N
* Biochemical and Structural Analysis of the Binding Determinants of a Vascular Endothelial Growth Factor Receptor Peptidic Antagonist (119 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2010 Jun 10; 53(11): 4428-4440.
Impact Factor: 5.207
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Zannetti A, Iommelli F, Lettieri A, Brunetti A, Salvatore M
* Molecular imaging of tumor microenvironment (113 visite)
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2010 Jun; 54(3): 243-258.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Zannetti A, Iommelli F, Lettieri A, Brunetti A, Salvatore M
* Molecular imaging of tumor microenvironment: Challenges and perspectives (175 visite)
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2010 Jun; 54(3): 249-258.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

Diana D, Ziaco B, Scarabelli G, Pedone C, Colombo G, D'Andrea LD, Fattorusso R
* Structural analysis of a helical peptide unfolding pathway (137 visite)
Chemistry (ISSN: 1521-3765, 0947-6539, 1521-3765electronic), 2010 May 10; 16(18): 5400-5407.
Impact Factor: 5.476
Dettagli    Esporta in BibTeX    Esporta in EndNote

Napolitano M, Ottaiano A, Mauro F, Ieranò C, Satriano R, Pacelli R, Franco R, De Angelis V, Castello G, Scala S
* CD4(+)CD45RA(+)CXCR4(+) lymphocytes are inversely associated with progression in stages I-III melanoma patients (87 visite)
Cancer Immunol Immunother (ISSN: 0340-7004, 0340-7004linking), 2010 Apr; 59(4): 511-517.
Impact Factor: 4.293
Dettagli    Esporta in BibTeX    Esporta in EndNote

Alberobello AT, D'Esposito V, Marasco D, Doti N, Ruvo M, Bianco R, Tortora G, Esposito I, Fiory F, Miele C, Beguinot F, Formisano P
* Selective Disruption of Insulin-like Growth Factor-1 (IGF-1) Signaling via Phosphoinositide-dependent Kinase-1 Prevents the Protective Effect of IGF-1 on Human Cancer Cell Death (108 visite)
J Biol Chem Journal Of Biological Chemistry (ISSN: 0021-9258, 1083-351x), 2010 Feb 26; 285(9): 6563-6572.
Impact Factor: 5.328
Dettagli    Esporta in BibTeX    Esporta in EndNote

Acampa W, Caprio MG, Nicolai E, Liuzzi R,  De Luca S, Capasso E, Luongo L, Petretta M, Cuocolo A
* Assessment of poststress left ventricular ejection fraction by gated SPECT: Comparison with equilibrium radionuclide angiocardiography (126 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Feb; 37(2): 349-356.
Impact Factor: 5.036
Dettagli    Esporta in BibTeX    Esporta in EndNote

Storto G, De Renzo A, Pellegrino T, Perna F, De Falco T, Erra P, Nardelli A, Speranza A, Klain M, Rotoli B, Pace L
* Assessment of Metabolic Response to Radioimmunotherapy with (90)Y-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (112 visite)
Radiology (ISSN: 0033-8419, 1527-1315, 0033-8419linking), 2010 Jan; 254(1): 245-252.
Impact Factor: 6.069
Dettagli    Esporta in BibTeX    Esporta in EndNote

Guler OO, De Simone G, Supuran CT
* Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII (201 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2010; 17(15): 1516-1526.
Impact Factor: 4.63
Dettagli    Esporta in BibTeX    Esporta in EndNote

Di Stasi R, Diana D, Capasso D, Palumbo R, Romanelli A, Pedone C, Fattorusso R, D'Andrea LD
* VEGFR1(D2) in drug discovery: Expression and molecular characterization (111 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2010; 94(6): 800-809.
Impact Factor: 2.572
Dettagli    Esporta in BibTeX    Esporta in EndNote

Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, Nagren K, Darcourt J, Tatsch K, Van Laere KJ
* EANM procedure guideline for brain perfusion SPECT using Tc-99m-labelled radiopharmaceuticals, version (165 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Dec; 36(12): 2093-2102.
Impact Factor: 4.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

Bellia F, Calabrese V, Guarino F, Cavallaro M, Cornelius C, De Pinto V, Rizzarelli E
* Carnosinase levels in aging brain: redox state induction and cellular stress response (154 visite)
Antioxid Redox Signal (ISSN: 1557-7716, 1523-0864), 2009 Nov; 11(11): 2759-2775.
Impact Factor: 7.581
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lucignani G, Cuocolo A
Recent advances in the assessment of myocardial viability (113 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2009 Nov; 36(11): 1892-1895.
Impact Factor: 4.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

Evangelista L, Acampa W, Ferro A, Daniele S, Xhoxhi E, De Rimini ML, Cittanti C, Marranzano F, Spadafora M, Baldari S, Mansi L, Cuocolo A
* Impact of Inducible Ischemia by Stress SPECT in Cardiac Risk Assessment in Diabetic Patients: Results of a Prospective, Multicenter Trial (66 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.
Impact Factor: 4.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

D'Andrea LD, Del Gatto A, De Rosa L, Romanelli A, Pedone C
* Peptides targeting angiogenesis related growth factor receptors (13888 visite)
Curr Pharm Des Current Pharmaceutical Design (ISSN: 1873-4286, 1381-6128), 2009 Jul; 15(21): 2414-2429.
Impact Factor: 4.414
Dettagli    Esporta in BibTeX    Esporta in EndNote

Santulli G, Ciccarelli M, Palumbo G, Campanile A, Galasso G, Ziaco B, Altobelli GG, Cimini V, Piscione F, D'Andrea LD, Pedone C, Trimarco B, Iaccarino G
* In vivo properties of the proangiogenic peptide QK (105 visite)
J Transl Med Journal Of Translational Medicine (ISSN: 1479-5876, 1479-5876electronic), 2009 Jun 8; 7: 41-41.
Impact Factor: 3.407
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mancini M, Greco A, Speranza A, Salvatore M
* Ultrasound molecular imaging by targeted microbubble contrast agents (150 visite)
Minerva Biotecnol (ISSN: 1120-4826), 2009 Jun; 21(2): 97-110.
Impact Factor: 0.268
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sandomenico A, Monti SM, Sabatella M, De Capua A, Tornatore L, Doti N, Viparelli F, Dathan NA, Pedone C, Ruvo M, Marasco D
* Protein-protein interactions: a simple strategy to identify binding sites and peptide antagonists (124 visite)
Chem Biol Drug Des Chemical Biology And Drug Design (ISSN: 1747-0285, 1747-0277), 2009 May; 73(5): 483-493.
Impact Factor: 2.473
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cho WG, Albuquerque RJ, Kleinman ME, Tarallo V, Greco A, Nozaki M, Green MG, Baffi JZ, Ambati BK, De Falco M, Alexander JS, Brunetti A, De Falco S, Ambati J
* Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth (116 visite)
Proc Natl Acad Sci U S A (ISSN: 0027-8424, 1091-6490, 0027-8424print), 2009 Apr 28; 106(17): 7137-7142.
Impact Factor: 9.432
Dettagli    Esporta in BibTeX    Esporta in EndNote

Kaczmarek K, Farina B, Zubrzak P, Jankowski S, Zimecki M, Suder P, Benedetti E, Fattorusso R, Saviano M, Zabrocki J
* Synthesis, conformational analysis and immunological activity of β3Phe-substituted Cyclolinopeptide A analogues (126 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2009 Mar; 15(3): 166-174.
Impact Factor: 1.807
Dettagli    Esporta in BibTeX    Esporta in EndNote

Evangelista L, Acampa W, Petretta M, Ferro A, Ricci F, Luongo L, Daniele S, Punzo G, Cuocolo A
* Incremental prognostic value of cardiac single-photon emission computed tomography after nitrate administration in patients with ischemic left ventricular dysfunction (111 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2009 Feb; 16(1): 38-44.
Impact Factor: 2.777
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cittadini A, Monti MG, Castiello MC, D'Arco E, Galasso G, Sorriento D, Saldamarco L, De Paulis A, Napoli R, Iaccarino G, Saccà L
* Insulin-like growth factor-1 protects from vascular stenosis and accelerates re-endothelialization in a rat model of carotid artery injury (111 visite)
J Thromb Haemost Journal Of Thrombosis And Haemostasis (ISSN: 1538-7933), 2009; 7(11): 1920-1928.
Impact Factor: 6.069
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sandomenico A, Marasco D, Monti SM, Saviano M, Pedone C, Benedetti E, Ruvo M
* Peptides binding the type E immunoglobulins (131 visite)
Adv Exp Med Biol (ISSN: 0065-2598, 0065-2598print), 2009; 611: 573-574.
Impact Factor: 2.02
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ponticelli S, Marasco D, Tarallo V, Albuquerque RJC, Mitola S, Takeda A, Stassen J, Presta M, Ambati J, Ruvo M, De Falco S
* Modulation of Angiogenesis by a Tetrameric Tripeptide That Antagonizes Vascular Endothelial Growth Factor Receptor (116 visite)
J Biol Chem Journal Of Biological Chemistry (ISSN: 0021-9258, 1083-351x), 2008 Dec 5; 283(49): 34250-34259.
Impact Factor: 5.52
Dettagli    Esporta in BibTeX    Esporta in EndNote

Salvatore B, Acampa W, Evangelista L, Ricci F, Costanzo P, Di Taranto MD, De Falco T, Vassallo S, Petretta M, Fortunato G, Cuocolo A
* Relationship Between Paraoxonase Polymorphisms and Stress-induced Myocardial Ischemia in Patients With Suspected Coronary Artery Disease (78 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
Dettagli    Esporta in BibTeX    Esporta in EndNote

Dudar GK, D'Andrea LD, Di Stasi R, Pedone C, Wallace JL
* A vascular endothelial growth factor mimetic accelerates gastric ulcer healing in an iNOS-dependent manner (146 visite)
Am J Physiol Gastrointest Liver Physiol American Journal Of Physiology Gastrointestinal And Liver Physiology (ISSN: 0193-1857), 2008 Sep; 295(2): G374-G374.
Impact Factor: 3.587
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ponticelli S, Takeda A, Mitola S, Stassen J, Presta M, Ambati J, Ruvo M, De Falco S, Marasco D
* Angiogenesis modulation: identification of tetrameric tripeptide as inhibitor of VEGFR-1 by the screening of peptide combinatiorial libraries (111 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2008 Sep; 14(8): N/D-N/D.
Impact Factor: 1.654
Dettagli    Esporta in BibTeX    Esporta in EndNote

Di Stasi R, Capasso D, Diana D, Fattorusso R, Pedone C, D'Andrea LD
* Vascular Endothelial Growth Factor (VEGF) and its receptors: key regulators of angiogenesis (96 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2008 Sep; 14(8): N/D-N/D.
Impact Factor: 1.654
Dettagli    Esporta in BibTeX    Esporta in EndNote

Acampa W, Petretta M, Evangelista L, Nappi G, Luongo L, Petretta MP, Cuocolo A
* Stress cardiac single-photon emission computed tomographic imaging late after coronary artery bypass surgery for risk stratification and estimation of time to cardiac events (98 visite)
J Thorac Cardiovasc Surg (ISSN: 0022-5223, 1097-685x), 2008 Jul; 136(1): 46-51.
Impact Factor: 3.037
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petretta M, Soricelli A, Storto G, Cuocolo A
* Assessment of coronary flow reserve using single photon emission computed tomography with technetium 99m-labeled tracers (139 visite)
J Nucl Cardiol (ISSN: 1532-6551, 1071-3581, 1532-6551electronic), 2008 May; 15(3): 456-465.
Impact Factor: 2.442
Dettagli    Esporta in BibTeX    Esporta in EndNote

Leese MP, Jourdan FL, Gaukroger K, Mahon MF, Newman SP, Foster PA, Stengel C, Regis-Lydi S, Ferrandis E, Di Fiore A, De Simone G, Supuran CT, Purohit A, Reed MJ, Potter BVL
* Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents (130 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2008 Mar 13; 51(5): 1295-1308.
Impact Factor: 4.898
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petretta M, Acampa W, Evangelista L, Daniele S, Ferro A, Cuocolo A
* Impact of inducible ischemia by stress SPECT in cardiac risk assessment in diabetic patients: Rationale and design of a prospective, multicenter trial (102 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2008 Jan; 15(1): 100-104.
Impact Factor: 2.442
Dettagli    Esporta in BibTeX    Esporta in EndNote

Diana D, Ziaco B, Colombo G, Scarabelli G, Romanelli A, Fedone C, Fattorusso R, D'Andrea LD
* Structural determinants of the unusual helix stability of a de novo engineered vascular endothelial growth factor (VEGF) mimicking peptide (124 visite)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2008; 14(14): 4164-4166.
Impact Factor: 5.454
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sorriento D, Ciccarelli M, Santulli G, Campanile A, Altobelli GG, Cimini V, Galasso G, Astone D, Piscione F, Pastore L, Trimarco B, Iaccarino G
* The G-protein-coupled receptor kinase 5 inhibits NFκB transcriptional activity by inducing nuclear accumulation of IκBα (97 visite)
Proc Natl Acad Sci U S A (ISSN: 0027-8424, 1091-6490, 0027-8424print), 2008; 105(46): 17818-17823.
Impact Factor: 9.38
Dettagli    Esporta in BibTeX    Esporta in EndNote

Costantino V, De Rosa C, Fattorusso E, Imperatore C, Mangoni A, Irace C, Maffettone C, Capasso D, Malorni L, Palumbo R, Pedone C
* Oreacerebrosides: Bioactive cerebrosides with a triunsaturated sphingoid base from the sea star Oreaster reticulatus (101 visite)
Eur J Org Chem (ISSN: 1434-193x), 2007 Nov; (31): 5277-5283.
Impact Factor: 2.914
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ferro A, Pellegrino T, Spinelli L, Acampa W, Petretta M, Cuocolo A
* Comparison Between Dobutamine Echocardiography and Single-Photon Emission Computed Tomography for Interpretive Reproducibility (97 visite)
Am J Cardiol (ISSN: 0002-9149), 2007 Oct 15; 100(8): 1239-1244.
Impact Factor: 3.603
Dettagli    Esporta in BibTeX    Esporta in EndNote

Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM
* Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity (224 visite)
Nature Reviews Neuroscience (ISSN: 1471-0048), 2007 Oct; 8(10): 766-775.
Impact Factor: 24.52
Dettagli    Esporta in BibTeX    Esporta in EndNote

Salvatore B, Acampa W, Fortunato G, Ricci F, Evangelista L, Di Lauro F, Petretta M, Cuocolo A
* Relation between stress-induced myocardial ischemia and C-reactive protein levels in patients with suspected coronary artery disease (80 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Oct; 34: N/D-N/D.
Impact Factor: 4.101
Dettagli    Esporta in BibTeX    Esporta in EndNote

Zannetti A, Fonti R, Iommelli F, Papaccioli A, Sommella J, Tortora G, Bianco R, Salvatore M, Del Vecchio S
* SPECT imaging of endoplasmic reticulum-mediated tumor response to gefitinib and erlotinib in lung cancer (129 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Oct; 34: 277-309.
Impact Factor: 4.101
Dettagli    Esporta in BibTeX    Esporta in EndNote

Acampa W, Evangelista L, Petretta M, Liuzzi R, Cuocolo A
* Usefulness of Stress Cardiac Single-Photon Emission Computed Tomographic Imaging Late After Percutaneous Coronary Intervention for Assessing Cardiac Events and Time to Such Events (101 visite)
Am J Cardiol (ISSN: 0002-9149), 2007 Sep 1; 100(3): 436-441.
Impact Factor: 3.603
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ntziachristos V, Cuénod CA, Fournier L, Balvay D, Pradel C, Siauve N, Clement O, Jouannot E, Lucidarme O, Vecchio SD, Salvatore M, Law B, Tung C-H, Jain RK, Fukumura D, Munn LL, Brown EB, Schellenberger E, Montet X, Weissleder R, Clerck ND, Postnov A
* Tumor Imaging (121 visite)
Textbook Of In Vivo Imaging In Vertebrates (ISSN: 9780-4700), 2007 Jul 16; 1: 277-309.
Impact Factor: 1.148
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M
* Nuclear imaging in cancer theranostics (194 visite)
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 152-163.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pappata S
* Tracking the dynamics of secondary degeneration after stroke (98 visite)
J Neurol Neurosurg Psychiatry (ISSN: 0022-3050), 2007 Jun; 78(6): 554-554.
Impact Factor: 3.857
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sorrentino AR, Acampa W, Petretta M, Mainolfi C, Salvatore M, Cuocolo A
* Comparison of the prognostic value of SPECT after nitrate administration and metabolic imaging by PET in patients with ischaemic left ventricular dysfunction (117 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Apr; 34(4): 558-562.
Impact Factor: 4.101
Dettagli    Esporta in BibTeX    Esporta in EndNote

Paladini D, Maruotti GM, Sglavo G, Fratellanza G, Quarantelli M, Martinelli P
* Massive fetal hemorrhage and fetomaternal alloimmune thrombocytopenia from human platelet antigen 5b incompatibility: An unusual association [2] (79 visite)
Ultrasound Obstet Gynecol (ISSN: 0960-7692, 1469-0705), 2007 Apr; 29(4): 471-474.
Impact Factor: 2.672
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A, Milcinski M, Bischof Delaloye A
* Syllabus for postgraduate specialisation in Nuclear Medicine: 2006/07 update (137 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Mar; 34(3): 433-436.
Impact Factor: 4.101
Dettagli    Esporta in BibTeX    Esporta in EndNote

Palmieri G, Marino M, Salvatore M, Budillon A, Meo G, Caraglia M, Montella L
* Cetuximab is an active treatment of metastatic and chemorefractory thymoma (92 visite)
Frontiers In Bioscience (ISSN: 1093-9946, 1093-4715), 2007 Jan 1; 12(2): 757-761.
Impact Factor: 2.989
Dettagli    Esporta in BibTeX    Esporta in EndNote

Evangelista L, Ferro A, Acampa W, Capasso R, De Rimini ML, Cittanti C, Marranzano F, Spadafora M, Baldari S, Mansi L, Petretta M, Cuocolo A
* A prospective, multi-center trial to assess the prevalence and the clinical predictors of myocardial ischemia in patients presenting with diabetes mellitus and suspected or documented coronary artery disease (89 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.
Impact Factor: 4.041
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Gatto A, Zaccaro L, Grieco P, Novellino E, Zannetti A, Del Vecchio S, Iommelli F, Salvatore M, Pedone C, Saviano M
* Novel And Selective Alpha (v) Beta3 Receptor Peptide Antagonist: Design, Synthesis, And Biological Behavior (173 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2006 Jun 1; 49(11): 3416-3420.
Impact Factor: 5.115
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A, Acampa W, Varrone A, Salvatore M
* Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: The incremental value of nuclear medicine for patient management and care (216 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Mar; 33(3): 360-381.
Impact Factor: 4.041
Dettagli    Esporta in BibTeX    Esporta in EndNote

Palumbo R, Capasso D, Brescia F, Mita P, Sarti M, Bersani F, Scarfi MR
* Effects on apoptosis and reactive oxygen species formation by Jurkat cells exposed to 50 Hz electromagnetic fields (82 visite)
Bioelectromagnetics (ISSN: 0197-8462), 2006 Feb; 27(2): 159-162.
Impact Factor: 1.514
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Gatto A, D'Andrea LD, Zaccaro L, Saviano M, Pedone C, Benedetti E
* Engineering Peptides In Angiogenesis (129 visite)
Biopolymers, 2006; 0: 215-216.
Impact Factor: 2.288
Dettagli    Esporta in BibTeX    Esporta in EndNote

D'Andrea LD, Iaccarino G, Fattorusso R, Sorriento D, Carannante C, Capasso D, Trimarco B, Pedone C
* Targeting angiogenesis: Structural characterization and biological properties of a de novo engineered VEGF mimicking peptide (149 visite)
Proc Natl Acad Sci U S A (ISSN: 0027-8424, 1091-6490, 0027-8424print), 2005 Oct 4; 102(40): 14215-14220.
Impact Factor: 10.231
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ferro A, Acampa W, De Rimini ML, Cittanti C, Marranzano F, Spadafora M, Mansi L, Capasso R, Reccia P, Petretta M, Cuocolo A
* A Prospective, Multi-Center Trial to Identify the Prevalence of Inducible Ischemia in Patients Presenting with Diabetes and Suspected or Known Coronary Artery Disease: Preliminary Results (142 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Sep; 32: N/D-N/D.
Impact Factor: 3.883
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ferro A, Spinelli L, Acampa W, Pellegrino T, Capacchione D, De Corato G, Petretta M, Cuocolo A
* Direct Comparison of Interpretative Reproducibility of Stress Myocardial Perfusion Imaging and Stress Echocardiography for the Detection of Inducible Ischemia (107 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Sep; 32: N/D-N/D.
Impact Factor: 3.883
Dettagli    Esporta in BibTeX    Esporta in EndNote

Acampa W, Spinelli L, Sorrentino AR, Capacchione D, Paone G, Petretta M, Salvatore M, Cuocolo A
* Comparison of prognostic value of negative dobutamine stress echocardiography versus single-photon emission computed tomography after acute myocardial infarction (97 visite)
Am J Cardiol (ISSN: 0002-9149), 2005 Jul 1; 96(1): 13-16.
Impact Factor: 3.059
Dettagli    Esporta in BibTeX    Esporta in EndNote

Verdoliva A, Marasco D, De Capua A, Saporito A, Bellofiore P, Manfredi V, Fattorusso R, Pedone C, Ruvo M
* A new ligand for immunoglobulin G subdomains by screening of a synthetic peptide library (126 visite)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-7633electronic), 2005 Jul; 6(7): 1242-1253.
Impact Factor: 3.94
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A
FDG imaging should be considered the preferred technique for accurate assessment of myocardial viability: against (78 visite)
Eur J Nucl Med (ISSN: 1619-7070print, 1619-7070linking, 1619-7089electronic), 2005 Jul; 32(7): 832-835.
Impact Factor: 3.883
Dettagli    Esporta in BibTeX    Esporta in EndNote

Acampa W, Petretta M, Spinelli L, Ibello F, De Lauro F, Sansone V, Salvatore M, Cuocolo A
* Survival benefit after revascularization is independent of left ventricular ejection fraction improvement in patients with previous myocardial infarction and viable myocardium (87 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Apr; 32(4): 430-437.
Impact Factor: 3.883
Dettagli    Esporta in BibTeX    Esporta in EndNote

Acampa W, Spinelli L, Petretta M, De Lauro F, Ibello F, Cuocolo A
* Prognostic value of myocardial ischemia in patients with uncomplicated acute myocardial infarction: Direct comparison of stress echocardiography and myocardial perfusion imaging (99 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2005 Mar; 46(3): 417-423.
Impact Factor: 4.684
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A, Acampa W, Imbriaco M, De Luca N, Iovino GL, Salvatore M
* The many ways to myocardial perfusion imaging (204 visite)
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2005 Mar; 49(1): 4-18.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

Iaccarino G, Ciccarelli M, Sorriento D, Galasso G, Campanile A, Santulli G, Cipolletta E, Cerullo V, Cimini V, Altobelli GG, Piscione F, Priante O, Pastore L, Chiariello M, Salvatore F, Koch WJ, Trimarco B
* Ischemic neoangiogenesis enhanced by β2-adrenergic receptor overexpression: A novel role for the endothelial adrenergic system (115 visite)
Circ Res (ISSN: 0009-7330, 1524-4571electronic), 2005; 97(11): 1182-1189.
Impact Factor: 9.408
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ferro A, Acampa W, Petretta M, Ibello F, Salvatore M, Cuocolo A
* A prospective, multi-center trial to identify the prevalence of inducible ischemia in patients presenting with diabetes and without known coronary artery disease: Preliminary results (81 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2004 Sep; 31: N/D-N/D.
Impact Factor: 3.935
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Catalano L, Pace L, Rotoli B, Salvatore M
* Functional Imaging Of Multidrug Resistant Phenotype By 99mtc-Mibi Scan In Patients With Multiple Myeloma (111 visite)
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2004; 19(2): 165-170.
Impact Factor: 1.091
Dettagli    Esporta in BibTeX    Esporta in EndNote

He W, Acampa W, Mainolfi C, Menna F, Sorrentino AR, Petretta M, Cuocolo A
* Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: Relation to metabolic imaging by PET (133 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2003 Nov; 10(6): 599-606.
Impact Factor: 1.629
Dettagli    Esporta in BibTeX    Esporta in EndNote

Spinelli L, Petretta M, Acampa W, He W, Petretta A, Bonaduce D, Cuocolo A
* Prognostic value of combined assessment of regional left ventricular function and myocardial perfusion by dobutamine and rest gated SPECT in patients with uncomplicated acute myocardial infarction (122 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2003 Jul; 44(7): 1023-1029.
Impact Factor: 4.899
Dettagli    Esporta in BibTeX    Esporta in EndNote

Acampa W, Petretta M, Florimonte L, Mattera A, Cuocolo A
* Prognostic value of exercise cardiac tomography performed late after percutaneous coronary intervention in symptomatic and symptom-free patients (102 visite)
Am J Cardiol (ISSN: 0002-9149), 2003 Feb 1; 91(3): 259-263.
Impact Factor: 3.059
Dettagli    Esporta in BibTeX    Esporta in EndNote

Russo M, Palumbo R, Mupo A, Tosto M, Iacomino G, Scognamiglio A, Tedesco I, Galano G, Russo GL
* Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Cα (141 visite)
Oncogene (ISSN: 0950-9232, 1476-5594), 2003; 22(21): 3330-3342.
Impact Factor: 6.495
Dettagli    Esporta in BibTeX    Esporta in EndNote

Acampa W, Petretta M, Cuocolo A
* Nuclear medicine procedures in cardiovascular diseases: An evidence based approach (213 visite)
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 2002 Dec; 46(4): 323-330.
Impact Factor: 1.903
Dettagli    Esporta in BibTeX    Esporta in EndNote

Rossi M, Manfredi V, Ruvo M, Fassina G, Verdoliva A
* Sequence-simplification and chimeric assembly: New models of peptide antigen modification (107 visite)
Mol Immunol Molecular Immunology (ISSN: 0161-5890), 2002 Nov; 39(7-8): 443-451.
Impact Factor: 2.414
Dettagli    Esporta in BibTeX    Esporta in EndNote

Maglio O, Saldanha JW, Vrtala S, Spitzauer S, Valenta R, Pastore A
* A major IgE epitope-containing grass pollen allergen domain from Phl p 5 folds as a four-helix bundle (106 visite)
Protein Eng (ISSN: 0269-2139print, 0269-2139linking), 2002 Aug; 15(8): 635-642.
Impact Factor: 2.126
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Zannetti A, Ciarmiello A, Aloj L, Caracò C, Fonti R, Botti G, D'Aiuto G, Salvatore M
* Dynamic coupling of Tc-99m-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients (128 visite)
Eur J Nucl Med (ISSN: 1619-7070, 0340-6997, 1619-7089), 2002 Jun; 29(6): 809-814.
Impact Factor: 3.568
Dettagli    Esporta in BibTeX    Esporta in EndNote

Marino M, Rossi M, Ruvo M, Fassina G
* Novel molecular targets for systemic lupus erythematosus (105 visite)
Curr Drug Targets (ISSN: 1389-4501), 2002 Jun; 3(3): 223-228.
Impact Factor: 3.597
Dettagli    Esporta in BibTeX    Esporta in EndNote

Salvatore M, Fonti R
* New frontiers of nuclear medicine (165 visite)
Tumori (ISSN: 0300-8916, 0300-8916print), 2002 May; 88(3): S60-S60.
Impact Factor: 0.267
Dettagli    Esporta in BibTeX    Esporta in EndNote

Orru S, Ruoppolo M, Francese S, Vitagliano L, Marino G, Esposito C
* Identification of tissue transglutaminase-reactive lysine residues in glyceraldehyde-3-phosphate dehydrogenase (9433 visite)
Protein Sci (ISSN: 0961-8368, 1469-896xelectronic), 2002 Jan; 11(1): 137-146.
Impact Factor: 3.546
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petretta M, Acampa W, Cuocolo A
* Myocardial viability assessment in regions of left ventricular dysfunction. Part I: Radionuclide imaging and clinical implications (86 visite)
Nuclear Medicine Communications (ISSN: 0143-3636, 1473-5628), 2001 Jun; 22(6): 607-611.
Impact Factor: 1.19
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A, Acampa W
* Nuclear cardiology in the new millennium (91 visite)
Rev Esp Med Nucl (ISSN: 0212-6982), 2001 Jun; 20(4): 305-308.
Impact Factor: 0.155
Dettagli    Esporta in BibTeX    Esporta in EndNote

Acampa W, Di Benedetto C, Cuocolo A
An overview of radiotracers in nuclear cardiology (97 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2000 Nov; 7(6): 701-707.
Impact Factor: 1.854
Dettagli    Esporta in BibTeX    Esporta in EndNote

Menna F, Acampa W, Florimonte L, Ferro A, Borrelli G, Mainolfi C, Cuocolo A
[Cardiac tomography with 99mTc-tetrofosmin after nitrate administration in patients with ischemic cardiopathy and left ventricular dysfunction] (103 visite)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 2000 Apr; 99(4): 258-263.
Impact Factor: 1.368
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A, Acampa W, Nicolai E, Pace L, Petretta M, Salvatore M
Quantitative thallium-201 and technetium 99m sestamibi tomography at rest in detection of myocardial viability in patients with chronic ischemic left ventricular dysfunction (116 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2000 Jan; 7(1): 8-15.
Impact Factor: 1.854
Dettagli    Esporta in BibTeX    Esporta in EndNote

Menna F, Acampa W, Florimonte L, Ferro A, Borrelli G, Mainolfi C, Cuocolo A
99mTc tetrofosmin cardiac tomography after nitrate administration in patients with coronary artery disease and left vetricular dysfunction (114 visite)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 2000; 99(4): 258-263.
Impact Factor: 1.368
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pace L, Nappi A, Imbriaco M, Cuocolo A, Varrone A, Romano M, Trimarco B, Salvatore M
Relationship between exercise capacity and left ventricular function at rest in patients with heart failure. An ambulatory left ventricular monitoring study (111 visite)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 2000; 100(3): 120-125.
Impact Factor: 1.368
Dettagli    Esporta in BibTeX    Esporta in EndNote

Russo M, Palumbo R, Tedesco I, Mazzarella G, Russo P, Iacomino G, Russo GL
Quercetin and anti-CD95(Fas/Apo1) enhance apoptosis in HPB-ALL cell line (96 visite)
Febs Lett (ISSN: 0014-5793, 0014-5793print, 1873-3468electronic), 1999 Dec 3; 462(3): 322-328.
Impact Factor: 3.72
Dettagli    Esporta in BibTeX    Esporta in EndNote

Nicolai E, Cuocolo A, Acampa W, Varrone A, Pace L, Salvatore M
Exercise-test Tc-99m tetrofosmin SPECT in patients with chronic ischemic left ventricular dysfunction: direct comparison with Ti-201 reinjection (95 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 1999 May; 6(3): 270-277.
Impact Factor: 1.765
Dettagli    Esporta in BibTeX    Esporta in EndNote

Tedeschi E, Marano I, Savarese F, Olibet G, Di Salvo E, Brunetti A, Sodano A
Neurological deficit following spinal anaesthesia: MRI and CT evidence of spinal cord gas embolism (101 visite)
Neuroradiology (ISSN: 0028-3940, 1432-1920electronic, 0028-3940linking), 1999 Apr; 41(4): 275-278.
Impact Factor: 1.287
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fonti R, Levchenko A, Mehta BM, Zhang J, Tsuruo T, Larson SM
Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography (86 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999 Jan; 26(1): 35-41.
Impact Factor: 1.623
Dettagli    Esporta in BibTeX    Esporta in EndNote

Monti SM, Fogliano V, Randazzo G, Peluso G, Logrieco A, Ritieni A
Polyclonal antibodies against fusaproliferin (78 visite)
Can J Microbiol (ISSN: 0008-4166), 1999 Jan; 45(1): 45-50.
Impact Factor: 1.072
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fonti R, Cheung N-KV, Bridger GJ, Guo H-F, Abrams MJ, Larson SM
99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors (101 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999; 26(6): 681-686.
Impact Factor: 1.623
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fonti R, Cheung NKV, Bridger GJ, Shen SQ, Finn RD, Abrams RJ, Larson SM
Technetium-99m-Monoclonal Antibody Radio-Labeled Via Hydrazino Nicotinamide Derivative For Imaging Ganglioside Gd2-Positive Tumors (85 visite)
Nucl Med Biol, 1999; 26: 681-686.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Renda A, Iovino F, Capasso L, Ricciardelli L, Tammaro V, Acampa W
Radioimmunoguided surgery in colorectal cancer: A 6-year experience with four different technical solutions (95 visite)
Semin Surg Oncol Wiley Liss Inc (ISSN: 8756-0437), 1998 Dec; 15(4): 226-230.
Impact Factor: 1.045
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fonti R, Latella G, Caprilli R, Frieri G, Marcheggiano A, Sambuy Y
Carbonic anhydrase I reduction in colonic mucosa of patients with active ulcerative colitis (80 visite)
Digestive Diseases And Sciences (ISSN: 0163-2116), 1998; 43(9): 2086-2092.
Impact Factor: 1.972
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Ciarmiello A, Pace L, Potena MI, Carriero MV, Mainolfi C, Thomas R, D'Aiuto G, Tsuruo T, Salvatore M
Fractional retention of technetium-99m-sestamibi as an index of P- glycoprotein expression in untreated breast cancer patients (89 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1997 Sep; 38(9): 1348-1351.
Impact Factor: 3.491
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A, Petretta M, Nicolai E, Pace L, Acampa W, Varrone A, Bonaduce D, Salvatore M
Prognostic value of coronary angiography in patients with chronic ischemic left ventricular dysfunction and evidence of viable myocardium at thallium-201 reinjection imaging (105 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1997 May; 38(5SUPPL.): 387-395.
Impact Factor: 3.491
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fogliano V, Monti SM, Ritieni A, Marchisano C, Peluso G, Randazzo G
An immunological approach to monitor protein lactosylation of heated food model systems (93 visite)
Food Chem (ISSN: 0308-8146, 0308-8146print), 1997; 58(1-2): 53-58.
Impact Factor: 0.812
Dettagli    Esporta in BibTeX    Esporta in EndNote

Levchenko A, Mehta B, Spengler BA, Narkar A, Fonti R, Biedler JL, Tsuruo T, Larson SM
Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay (104 visite)
Anal Biochem (ISSN: 0003-2697, 1096-0309electronic), 1996 May 1; 236(2): 338-343.
Impact Factor: 2.017
Dettagli    Esporta in BibTeX    Esporta in EndNote

Li PY, Del Vecchio S, Fonti R, Carriero MV, Potena MI, Botti G, Miotti S, Lastoria S, Menard S, Colnaghi MI, Salvatore M
Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography (158 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1996 Apr; 37(4-6): 665-672.
Impact Factor: 3.491
Dettagli    Esporta in BibTeX    Esporta in EndNote

Latella G, Fonti R, Caprilli R, Marcheggiano A, Magliocca F, Das KM, Gambús G, Sambuy Y
Characterization of the mucins produced by normal human colonocytes in primary culture (93 visite)
International Journal Of Colorectal Disease (ISSN: 0179-1958, 0179-1958linking), 1996; 11(2): 76-83.
Impact Factor: 0.732
Dettagli    Esporta in BibTeX    Esporta in EndNote

Maurea S, Cuocolo A, Soricelli A, Castelli L, Nappi A, Trimarco B, Salvatore M
Technetium-99m MIBI SPECT to identify viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction (105 visite)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 1996; 92(3): 289-296.
Impact Factor: 0.967
Dettagli    Esporta in BibTeX    Esporta in EndNote

Russo R, Rao MA,  Romano M, Scotto di Santolo M, Cardei S, Giunta A, Cuocolo A, Volpe M
Prospects of pharmacologic treatment of post-ischemic heart failure (61 visite)
Cardiologia (ISSN: 0393-1978), 1995 Dec; 40(12Suppl1): 533-537.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ferraro S, Cuocolo A, Nappi A, Trimigliozzi P, D'Alto M, Storto G, Sullo P, Salvatore M, Chiariello M
The short- and medium-term ambulatory radionuclide study of left ventricular function (VEST) after aortocoronary bypass (88 visite)
Cardiologia (ISSN: 0393-1978), 1995 Sep; 40(9): 659-665.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A, Pace L, Maurea S, Nappi A, Nicolai E, Imbriaco M, Sullo P, Cardei S, Salvatore M
Morpho-functional diagnostic imaging in the assessment of viable myocardium in patients with ischemic heart disease. Correlations between myocardial perfusion and regional function of the left ventricle (98 visite)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 1995 Jun; 89(6): 870-875.
Impact Factor: 0.967
Dettagli    Esporta in BibTeX    Esporta in EndNote

Carriero MV, Franco P, Del Vecchio S, Massa O, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M
Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies (107 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1994 Oct 15; 54(20): 5445-5454.
Impact Factor: 8.426
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caraglia M, Tagliaferri P, Correale P, Genua G, Pinto A, Del Vecchio S, Esposito G, Bianco AR
CYTOSINE-ARABINOSIDE INCREASES THE BINDING OF I-125 LABELED EPIDERMAL GROWTH-FACTOR AND I-125 TRANSFERRIN AND ENHANCES THE IN-VITRO TARGETING OF HUMAN TUMOR-CELLS WITH ANTI-(GROWTH FACTOR-RECEPTOR) MAB (118 visite)
Cancer Immunol Immunother (ISSN: 0340-7004, 0340-7004linking), 1993 Sep; 37(3): 150-156.
Impact Factor: 1.269
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sofia M, Del Vecchio S, Petrillo A, Mormile M, Salvatore M, Carratù L
Endobronchial deposition of radioactive monoclonal antibody in patients with inoperable non-small-cell carcinoma of the lung [4] (88 visite)
Chest (ISSN: 0012-3692), 1992 Nov; 102(5): 1632-1634.
Impact Factor: 2.341
Dettagli    Esporta in BibTeX    Esporta in EndNote

Della Ragione F, Oliva A, Palumbo R, Russo GL, Gragnaniello V, Zappia V
Deficiency of 5'-deoxy-5'-methylthioadenosine phosphorylase activity in malignancy. Absence of the protein in human enzyme-deficient cell lines (74 visite)
Biochem J (ISSN: 0264-6021print, 0264-6021linking, 1470-8728electronic), 1992 Jan 15; 281(Pt2): 533-538.
Impact Factor: 3.579
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A, Nappi A, Nicolai E, Pace L, Imbriaco M, Morisco C, Chiariello M, Trimarco B, Salvatore M
Ambulatory monitoring of left ventricular function: the assessment of transient episodes of ventricular dysfunction in patients with ischemic cardiopathy (93 visite)
G Ital Cardiol (ISSN: 0046-5968), 1992; 22(7): 813-824.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Perrella O, Liguori G, Cattaneo D, Morelli L, Precchia E, Morisco E, Fonti R, Marinelli P
Ig antibody levels to Helicobacter pylori and histology of antral gastritis and duodenal ulcer: What is the correlation? (72 visite)
G Mal Infett Parassit (ISSN: 0017-0321), 1992; 44(1): 65-68.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Perrella O, Liguori G, Cattaneo D, Morelli L, Precchia E, Morisco E, Fonti R, Marinelli P
Ig antibody levels to Helicobacter pylori and histology of antral gastritis and duodenal ulcer: What is the correlation? [LIVELLI DI IG AD ISOTIPO DIVERSO E QUADRO ISTOLOGICO NELLA PATOLOGIA GASTRICA ASSOCIATA ALL'HELICOBACTER PYLORI: QUALE CORRELAZIONE?] (66 visite)
G Mal Infett Parassit (ISSN: 0017-0321), 1992; 44: 65-68.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

D'Aiuto G, Del Vecchio S, Mansi L, D'Aprile M, Botti G, Salvatore M
Malignant melanoma of the nipple: A case studied with radiolabeled monoclonal antibody (105 visite)
Tumori (ISSN: 0300-8916, 0300-8916print), 1991 Oct 31; 77(5): 449-451.
Impact Factor: 0.408
Dettagli    Esporta in BibTeX    Esporta in EndNote

Manna R, Salvatore M, Di Leo MA, Scuderi F, Greco AV, Ghirlanda G, Gambassi G
Relationship between urinary neopterin excretion and islet cell antibodies in type 1 (insulin-dependent) diabetes (93 visite)
Diabetes Res (ISSN: 0265-5985), 1991 May; 17(1): 33-36.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Camera L, Del Vecchio S, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M
Evaluation of therapeutic response using iodine-131-B72. 3 monoclonal antibody in patients with ovarian carcinoma (118 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991 Apr; 18(4): 269-273.
Impact Factor: 2.692
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Camera L, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M
Clinical studies with B72. 3 in ovarian cancer and probe-guided tumor localization (113 visite)
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1991; 18(1): 85-87.
Impact Factor: 1.042
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Mansi L, Petrillo A, Camera L, Sofia M, Marra A, Carratú L, Salvatore M
Endobronchial administration of iodine-131 B72. 3 monoclonal antibody in patients with lung cancer (107 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991; 18(2): 129-132.
Impact Factor: 2.692
Dettagli    Esporta in BibTeX    Esporta in EndNote

Valenza V, Maussier ML, D'Errico G, Lemmo GF, Frontera D, Ferrante A, Saletnich I, Valli A, Quarantelli M
Cancer of the pancreas and the periampullary region: The usefulness of tumor marker products with the monoclonal antibody technique (76 visite)
J Nucl Med Allied Sci (ISSN: 0392-0208), 1990 Oct; 34(4SUPPL.): 131-134.
Impact Factor: 1.91
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Reynolds JC
NONUNIFORM DISTRIBUTION OF RADIOLABELED MONOCLONAL-ANTIBODY IN TUMOR (92 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1990 Jul; 31(7): 1252-1252.
Impact Factor: 3.491
Dettagli    Esporta in BibTeX    Esporta in EndNote

Trischitta V, Wong KY,  Brunetti A, Scalisi R, Vigneri R, Goldfine ID
Endocytosis, recycling, and degradation of the insulin receptor. Studies with monoclonal antireceptor antibodies that do not activate receptor kinase (88 visite)
J Biol Chem Journal Of Biological Chemistry (ISSN: 0021-9258, 1083-351x), 1989 Mar 25; 264(9): 5041-5046.
Impact Factor: 6.963
Dettagli    Esporta in BibTeX    Esporta in EndNote

d'Onofrio G, Menichella G, Zini G, Rumi C, Pierelli L, Quarantelli M, Puggioni PL, Mango G
Lymphocyte subset counting by immunoperoxidase using an automated routine hematologic analyzer (90 visite)
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 1989 Mar; 74(2): 137-142.
Impact Factor: 2.56
Dettagli    Esporta in BibTeX    Esporta in EndNote

Reynolds JC, Del Vecchio S, Sakahara H, Lora ME, Carrasquillo JA, Neumann RD, Larson SM
ANTI-MURINE ANTIBODY RESPONSE TO MOUSE MONOCLONAL ANTIBODIES CLINICAL FINDINGS AND IMPLICATIONS (90 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1989; 16(2): 121-125.
Impact Factor: 1.042
Dettagli    Esporta in BibTeX    Esporta in EndNote

Salvatore M, Lastoria S, Del Vecchio S, Mansi L
Detection of colon cancer with radiolabelled monoclonal antibodies (107 visite)
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1989; 16(2): 103-104.
Impact Factor: 1.042
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Reynolds JC
DETERMINATION OF ANTIGEN CONCENTRATION AND DISTRIBUTION IN HUMAN TUMORS THE QUANTITATIVE AUTORADIOGRAPHIC APPROACH (91 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1989; 16(2): 143-145.
Impact Factor: 1.042
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Reynolds JC, Carrasquillo JA, Blasberg RG, Neumann RD, Lotze MT, Bryant GJ, Farkas RJ, Larson SM
Local distribution and concentration of intravenously injected 131I-9. 2. 27 monoclonal antibody in human malignant melanoma (97 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1989; 49(10): 2783-2789.
Impact Factor: 8.426
Dettagli    Esporta in BibTeX    Esporta in EndNote

Manna R, Salvatore M, Scuderi F, Papa G, Marietti G, Greco AV, Ghirlanda G, Gambassi G
Negative correlation between ICA persistence and beta cell restoration after IDDM diagnosis (79 visite)
Diabetes Res (ISSN: 0265-5985), 1988 Nov; 9(3): 101-103.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

DEL VECCHIO S, MANSI L, GAGLIARDI N, PETRILLO A, SOFIA M, CARRATU L, SALVATORE M
INTRABRONCHIAL ADMINISTRATION OF IODINE-131 B72. 3 MONOCLONAL ANTIBODY IN PATIENTS WITH LUNG CANCER (83 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1988; 14(5-6): N/D-N/D.
Impact Factor: 2.692
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Reynolds JC, Blasberg RG, Neumann RD, Carrasquillo JA, Hellström I, Larson SM
Measurement of local Mr 97, 000 and 250, 000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiography (102 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1988; 48(19): 5475-5481.
Impact Factor: 8.426
Dettagli    Esporta in BibTeX    Esporta in EndNote



234 Records (213 escludendo Abstract e Conferenze).
Impact factor totale: 821.509 (759.621 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 870.257 (800.565 escludendo Abstract e Conferenze).







    Esporta in BibTeX    Esporta in EndNote

Ultima modifica di Marco Comerci in data Thursday 19 March 2015, 12:45:16
154 visite. Ultima visita in data Sunday 30 December 2018, 15:13:53

Webmaster and developer: Marco Comerci
Per problemi e suggerimenti: adminibb.cnr.it
Ultimo aggiornamento: Friday 15 February 2019, 13:06:47